UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K


ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2023

or


TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-3722

ATLANTIC AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)

Georgia
 
58-1027114
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
4370 Peachtree Road, N.E.,
Atlanta, Georgia
 
30319
(Address of principal executive offices)
 
(Zip Code)

(Registrant’s telephone number, including area code) (404) 266-5500
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $1.00 per share
AAME
NASDAQ Global Market

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer
Smaller reporting company
Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

The aggregate market value of common stock held by non-affiliates of the registrant as of June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, was $7,887,231. For purposes hereof, beneficial ownership is determined under rules adopted pursuant to Section 13 of the Securities Exchange Act of 1934, and the foregoing excludes value ascribed to common stock that may be deemed beneficially owned by the directors and executive officers, and 10% or greater stockholders, of the registrant, some of whom may not be deemed to be affiliates upon judicial determination. On February 29, 2024, there were 20,402,288 shares of the registrant’s common stock, par value $1.00 per share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive Proxy Statement for the 2024 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year end, have been incorporated by reference in Items 10, 11, 12, 13 and 14 of Part III of this Form 10-K.



TABLE OF CONTENTS

   
Page
     
 
3
     
PART I

 
Item 1.
4
 
4
 
5
 
6
 
6
 
7
 
8
 
9
 
9
 
10
 
10
 
11
 
11
 
12
 
12
 
12
 
12
     
Item 1A.
13
Item 1B.
13
Item 1C.
13
Item 2.
14
Item 3.
14
Item 4.
14
     
PART II
   
Item 5.
15
Item 6.
15
Item 7.
16
Item 7A.
23
Item 8.
24
Item 9.
58
Item 9A.
58
Item 9B.
59
Item 9C.
59
     
PART III
   
Item 10.
Directors, Executive Officers and Corporate Governance
60
Item 11.
Executive Compensation
60
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
60
Item 13.
Certain Relationships and Related Transactions, and Director Independence
60
Item 14.
Principal Accountant Fees and Services
60
     
PART IV
   
Item 15.
61
Item 16.
62
     
 
63
 
64
 
67
 
69
 
70

FORWARD-LOOKING STATEMENTS

Certain of the statements contained or incorporated by reference herein are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are all statements other than those of historical fact. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, and include estimates and assumptions related to, among other things, general economic, competitive, operational and legislative developments, expectations and trends. Forward-looking statements are inherently subject to risks and uncertainties which are, in many instances, beyond the Company’s control and have been made based upon management’s current expectations and beliefs concerning future developments and their potential effect upon the Company. There can be no assurance that future developments will be in accordance with management’s expectations or that the effect of future developments on the Company will be those anticipated by management. Actual results could differ materially from those expressed by forward-looking statements, depending on the occurrence or outcome of various factors. These factors include, among others: the effects of macroeconomic conditions and general economic uncertainty; unexpected developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated increases in the rate, number and amounts of claims outstanding; our ability to remediate the identified material weakness in our internal control over financial reporting; the level of performance of reinsurance companies under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company’s statutory capital levels; the uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the potential impact of public health emergencies, such as COVID-19; the incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of regulatory developments, including those which could increase the Company’s business costs and required capital levels; the Company’s ability to distribute its products through distribution channels, both current and future; the uncertain effect of emerging claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; information technology system failures or network disruptions; and risks related to cybersecurity matters, such as breaches of our computer network or those of other parties or the loss of or unauthorized access to the data we maintain. As a result, undue reliance should not be placed upon forward-looking statements, which speak only as of the date they are made.  The Company undertakes no obligation to publicly update any forward-looking statements as a result of subsequent developments, changes in underlying assumptions or facts or otherwise, except as may be required by law.
PART I

Item 1.
Business

The Company

Atlantic American Corporation, a Georgia corporation incorporated in 1968 (the “Parent” or “Company”), is a holding company that operates through its subsidiaries in well-defined specialty markets within the life and health and property and casualty insurance industries. The Parent’s principal operating subsidiaries are American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as “Bankers Fidelity”) within the life and health insurance industry. Each of American Southern and Bankers Fidelity is managed separately based upon the type of products it offers and is evaluated on its individual performance. The Company’s strategy is to focus on well-defined geographic, demographic and/or product niches within the insurance marketplace. Each of American Southern and Bankers Fidelity operates with relative autonomy, which structure is designed to allow for quick reaction to market opportunities.

The Parent has no significant business operations of its own and relies on fees, dividends and other distributions from its operating subsidiaries as the principal source of cash flow to meet its obligations. Additional information regarding the cash flow and liquidity needs of the Parent can be found in the Liquidity and Capital Resources section of Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Property and Casualty Operations

American Southern comprises the Company’s property and casualty operations and its primary product lines are as follows:

Commercial Automobile Insurance policies provide bodily injury and/or property damage liability coverage, uninsured motorist coverage and physical damage coverage for commercial accounts.

General Liability Insurance policies cover bodily injury and/or property damage liability for both premises and completed operations exposures for general classes of business.

Surety Bonds are contracts under which one party, the insurance company issuing the surety bond, guarantees to a third party that the primary party will fulfill an obligation in accordance with a contractual agreement. This obligation may involve meeting a contractual commitment, paying a debt or performing certain duties.

American Southern provides tailored commercial automobile insurance coverage, on a multi-year contract basis, to state governments, local municipalities and other large motor pools and fleets (“block accounts”) that can be specifically rated and underwritten. The size of the block accounts insured by American Southern are generally such that individual class experience can be determined, which allows for customized policy terms and rates. American Southern is licensed to do business in 32 states and the District of Columbia. While the majority of American Southern’s premiums are derived from its automobile lines of business, American Southern also offers general liability and other lines such as inland marine coverage. Additionally, American Southern directly provides surety bond coverage for subdivision construction, school bus contracts, as well as performance and payment bonds.

The following table summarizes, for the periods indicated, the allocation of American Southern’s net earned premiums from each of its principal product lines:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Automobile liability
 
$
38,821
   
$
33,981
 
Automobile physical damage
   
15,046
     
21,069
 
General liability
   
5,758
     
5,871
 
Surety
   
6,303
     
6,039
 
Other lines
   
2,515
     
3,316
 
Total
 
$
68,443
   
$
70,276
 

Life and Health Operations

Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplement and other accident and health insurance products.

Life Insurance products include non-participating, individual and group whole life insurance policies with a variety of riders and options. Policy premiums are dependent upon a number of factors, including issue age, level of coverage and selected riders or options.

Medicare Supplement Insurance includes 8 of the 10 standardized Medicare supplement policies created under the Medicare Improvements for Patients and Providers Act of 2008 (“MIPPA”), which are designed to provide insurance coverage for certain expenses not covered by the Medicare program, including copayments and deductibles.

Other Accident and Health Insurance coverages include several individual and group policies providing for the payment of standard benefits in connection with the treatment of diagnosed cancer and other critical illnesses, as well as a number of other policies providing short-term nursing facility care, accident only, hospital indemnity and disability coverages.

Health insurance products, primarily Medicare supplement insurance, accounted for 83% of Bankers Fidelity’s net earned premiums in 2023 while life insurance, including both whole and term life insurance policies, accounted for the balance. In terms of the number of policies written in 2023, 63% were health insurance policies and 37% were life insurance policies.

The following table summarizes, for the periods indicated, the allocation of Bankers Fidelity’s net earned premiums from each of its principal product lines:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Life insurance
 
$
18,584
   
$
15,805
 
Medicare supplement
   
77,425
     
86,970
 
Other accident and health
   
14,373
     
12,389
 
Total health insurance
   
91,798
     
99,359
 
Total
 
$
110,382
   
$
115,164
 

Marketing

Property and Casualty Operations

A portion of American Southern’s business is marketed through a small number of specialized, experienced independent agents. American Southern’s agent selection process is actively managed by internal marketing personnel with oversight from management. Senior management carefully reviews all new programs prior to acceptance. American Southern solicits business through multiple channels.  Most of American Southern’s agents are paid an up-front commission with the potential for additional commissions by participating in a profit sharing arrangement that is directly linked to the profitability of the underlying business. American Southern also solicits business from governmental entities. As an experienced writer of insurance policies for certain governmental programs, the company actively pursues this market on a direct basis. Much of this business is priced by means of competitive bid situations. As a result, there can be no assurance with respect to the ultimate profitability or ability of the Company to obtain or retain such business at the time of a specific contract renewal.

Life and Health Operations

Bankers Fidelity acquires its clientele through three distribution channels spread across 46 different states and two business divisions, all of which utilize commissioned, independent agents. The three distribution channels include traditional independent agents, brokers typically interested in a specific product of Bankers Fidelity and brokers who focus on sales within the group/employer benefits division, Atlantic American Employee Benefits, all of which are responsible for their own marketing and sales activities. Contracting as independent agents enables Bankers Fidelity to effectively expand or contract its sales force without incurring significant expense.

Bankers Fidelity had approximately 4,639 licensed agents contracted in both the individual and group divisions as of December 31, 2023. During 2023, approximately 454 of these licensed agents wrote policies on behalf of Bankers Fidelity.

Bankers Fidelity’s marketing and distribution strategy revolves around five pillars: Diversification, Differentiation, Quality, Retention and Profitability.

Diversification. Through unique product offerings such as the Vantage Flex Plus®, a hospital indemnity plan, and Vantage Recovery®, short-term care product and a group whole life product featuring a chronic illness rider, the Company is able to offer its distributors an array of products to sell that stand out from the competition. As the Company continues to expand its geographical footprint with agents and products, one of its main objectives is to have a healthy mix of all of its product lines nationwide.

Differentiation. Bankers Fidelity prides itself on the quality of customer service it offers to policyholders and agents. A dedicated agent support team is available to the field to support them on administration, underwriting, sales training, product questions and a plethora of other services which differentiates the Company from other carriers. Additionally, a customer loyalty team is available solely to serve insureds for any of their insurance needs. Bankers Fidelity prides itself on being agile, which we believe differentiates us from larger carriers and helps the Company to quickly execute senior management’s initiatives.

Quality. Bankers Fidelity is focused on being a niche carrier that delivers superior service, quality products and innovative solutions. Sophisticated technology and reporting allows the home office teams to work with the sales force to deliver a tailored experience and phenomenal customer service.

Retention. Through seasonal campaigns and customer outreach, the Company is focused on client retention and servicing its policyholders through all stages in their lives. By providing its agents with an innovative product portfolio, the Company further promotes client retention by empowering its agents to continually meet the needs of our policyholders.

Profitability. In an effort to be sustainable in the marketplace as a long-term partner, senior management is focused on diversification, differentiation, quality and retention to achieve profitability.

Underwriting

Property and Casualty Operations

American Southern specializes in underwriting various risks that are sufficiently large enough to establish separate class experience, relying upon the underwriting expertise of its agents.

During the course of the policy life, extensive use is made of risk management representatives to assist commercial underwriters in identifying and correcting potential loss exposures and to physically inspect new accounts. The underwriting results from each insured are reviewed on an individual basis periodically. If results are below expectations, management takes corrective action, which may include adjusting rates, revising underwriting standards, adjusting commissions paid to agents, and/or altering or declining to renew accounts at expiration.

Life and Health Operations

Bankers Fidelity issues a variety of products that span from the group markets to the individual markets for both life and health insurance. Products offered by Bankers Fidelity include life insurance, typically with small face amounts, Medicare supplement and other accident and health insurance. Bankers Fidelity also provides an array of group products such as accident, cancer, critical illness, hospital indemnity and life insurance that is offered to employers who are looking to provide coverage for their employees and have the related premiums deducted through payroll deductions.

The individual products are underwritten on a non-medical basis using a simplified issue approach by which an application containing a variety of health related questions is submitted. Applications for insurance are reviewed to determine the face amount, age, medical history and any other necessary information. Bankers Fidelity utilizes information obtained directly from the insured, the medical claims data, prescription utilization reports as well as telephone interviews to determine whether an applicant meets the Company’s underwriting criteria. Bankers Fidelity may also utilize medical records and investigative services to supplement and substantiate information, as necessary.

The group products are underwritten and assessed at the group level for financial risk.  The underwriting will utilize several factors to determine this risk such as the industry, demographics, enrollment strategies, employee access, locations of offices and any regulatory or legislative changes that could impact the decisions. The spread of risk is also reviewed which analyzes the content of the employees within the group which includes the spread of gender, ages, salaries and occupations.   This information is used to quote an appropriate benefits package, pricing, waiting periods and rates for the group entity.

Policyholder and Claims Services

The Company believes that prompt, efficient policyholder and claims services are essential to its continued success in marketing its insurance products (see “Competition”). Additionally, the Company believes that its insureds are particularly sensitive to claims processing time and to the accessibility of qualified staff to answer inquiries. Accordingly, the Company’s policyholder and claims services seek to offer expeditious disposition of service requests by providing toll-free access for all customers, 24-hour claim reporting services, and direct computer links with some of its largest accounts. The Company also utilizes an automatic call distribution system designed to ensure that inbound calls to customer service support groups are processed efficiently. Operational data generated from this system allows management to further refine ongoing client service programs and service representative training modules.

Property and Casualty Operations

American Southern controls its claims costs by utilizing an in-house staff of claims supervisors to investigate, verify, negotiate and settle claims. Upon notification of an occurrence purportedly giving rise to a claim, a claim file is established. The claims department then conducts a preliminary investigation, determines whether an insurable event has occurred and, if so, updates the file for the findings and any required reserve adjustments. Independent adjusters and appraisers are frequently utilized to service claims which require on-site inspections.

Life and Health Operations

The majority of life and health claims are filed electronically while insureds also have the ability to download claims forms and file directly. Insureds may also obtain claim forms by calling the customer service group or through Bankers Fidelity’s website.  All of these claims are entered into the system immediately upon receipt and put into a pending status until the claim can be fully processed.  To shorten claim processing time, a letter detailing all supporting documents that are required to complete a claim for a particular policy is sent to the customer along with the correct claim form. Properly documented claims are generally paid within five business days of receipt. With regard to Medicare supplement policies, the claim is either directly billed to Bankers Fidelity by the provider or sent electronically through a Medicare clearing house.

Reserves

Reserves are set by line of business within each of the subsidiaries. At December 31, 2023, approximately 73% of the losses and claims reserves related to property and casualty and approximately 27% related to life and health. The Company’s property and casualty operations incur losses which may take extended periods of time to evaluate and settle. Issues with respect to legal liability, actual loss quantification, legal discovery and ultimate subrogation, among other factors, may influence the initial and subsequent estimates of loss. In the property and casualty operations, the Company’s general practice is to reserve at the higher end of the determined reasonable range of loss if no other value within the range is determined to be more probable. The Company’s life and health operations generally incur losses which are more readily quantified. Medical claims received are recorded in case reserves based on contractual terms using the submitted billings as a basis for determination. Life claims are recorded based on contract value at the time of notification to the Company; offset by policy reserves related to such contracts previously established. Individual case reserves are established by a claims processor on each individual claim and are periodically reviewed and adjusted as new information becomes known during the course of handling a claim. Regular internal periodic reviews are also performed by management to ensure that loss reserves are established and revised timely relative to the receipt of new or additional information. Lines of business for which loss data (e.g. paid losses and case reserves) emerge over a long period of time are referred to as long-tail lines of business. Lines of business for which loss data emerge more quickly are referred to as short-tail lines of business. The Company’s long-tail line of business generally consists of its general liability coverage while the short-tail lines of business generally consist of property and automobile coverages.

The Company’s actuaries regularly review reserves for both current and prior accident years using the most current claims data. These reviews incorporate a variety of actuarial methods (discussed in Critical Accounting Policies) and judgments and involve a disciplined analysis. For most lines of business, certain actuarial methods and specific assumptions are deemed more appropriate based on the current circumstances affecting that line of business. These selections incorporate input from claims personnel and operating management on reported loss cost trends and other factors that could affect the reserve estimates.

The Company establishes reserves for claims based upon: (a) management’s estimate of ultimate liability and claims adjusters’ evaluations of unpaid claims reported prior to the close of the accounting period, (b) estimates of incurred but not reported (“IBNR”) claims based on past experience, and (c) estimates of losses and loss adjustment expense (“LAE”). The estimated liability is periodically reviewed and updated, and changes to the estimated liability are recorded in the statement of operations in the period in which such changes become known.

For long-tail lines of business, the emergence of paid losses and case reserves is less credible in the early periods, and accordingly may not be indicative of ultimate losses. For these lines, methods which incorporate a development pattern assumption are given less weight in calculating IBNR for the early periods of loss emergence because such a low percentage of ultimate losses are reported in that time frame. Accordingly, for any given accident year, the rate at which losses on long-tail lines of business emerge in the early periods is generally not as reliable an indication of ultimate losses as it would be for shorter-tail lines of business. The estimation of reserves for these lines of business in the early periods of loss emergence is therefore largely influenced by statistical analyses and application of prior accident years’ loss ratios, after considering changes to earned pricing, loss costs, mix of business, ceded reinsurance and other factors that are expected to affect the estimated ultimate losses. For later periods of loss emergence, methods which incorporate a development pattern assumption are given more weight in estimating ultimate losses. For short-tail lines of business, the emergence of paid loss and case reserves is more credible in the early periods and is more likely to be indicative of ultimate losses. The method used to set reserves for these lines of business is based upon utilization of a historical development pattern for reported losses. IBNR reserves for the current year are set as the difference between the estimated fully developed ultimate losses for each year, less the established, related case reserves and cumulative related payments. IBNR reserves for prior accident years are similarly determined, again relying on an indicated, historical development pattern for reported losses.

Based on the results of regular reserve estimate reviews, the Company determines the appropriate reserve adjustment, if any, to record in each period. If necessary, recorded reserve estimates are changed after consideration of numerous factors, including, but not limited to, the magnitude of the difference between the actuarial indication and the recorded reserves, improvement or deterioration of actuarial indication in the period, the maturity of the accident year, trends observed over the recent past and the level of volatility within a particular line of business. In general, changes are made more quickly to recognize changes in estimates to ultimate losses in mature accident years and less volatile lines of business.

The Company’s policy is to record reserves for losses and claims in amounts that represent actuarial best estimates of ultimate values. Actuarial best estimates do not necessarily represent the midpoint value determined using the various actuarial methods; however, such estimates will fall between the estimated low and high end reserve values. The range of estimates developed in connection with the December 31, 2023 actuarial review indicated that reserves could be as much as 16.9% lower or as much as 18.3% higher. In the opinion of management, recorded reserves represent the best estimate of outstanding losses, although significant judgments are made in the derivation of reserve estimates and revisions to such estimates are expected to be made in future periods. Any such revisions could be material, and may materially adversely affect the Company’s financial condition and results of operations in any future period.

Property and Casualty Operations

American Southern maintains loss reserves representing estimates of amounts necessary for payment of losses and LAE, which are not discounted. IBNR reserves are also maintained for future development. These loss reserves are estimates, based on known facts and circumstances at a given date, of amounts the Company expects to pay on incurred claims. All balances are reviewed periodically by the Company’s independent consulting actuary. Reserves for LAE are intended to cover the ultimate costs of settling claims, including investigation and defense of any lawsuits resulting from such claims. Loss reserves for reported claims are based on a case-by-case evaluation of the type of claim involved, the circumstances surrounding the claim, and the policy provisions relating to the type of loss along with anticipated future development. The LAE for claims reported and claims not reported is based on historical statistical data and anticipated future development. Inflation and other factors which may affect claim payments are implicitly reflected in the reserving process through analysis and consideration of cost trends and reviews of historical reserve results.

Estimating case reserves and ultimate losses involves various considerations which differ according to the line of business. In addition, changes in legislative and regulatory environments may impact loss estimates. General liability claims may have a long pattern of loss emergence. Given the broad nature of potential general liability coverages, investigative time periods may be extended and questions of coverage may exist. Such uncertainties create greater imprecision in estimating required levels of loss reserves. The property and automobile lines of business generally have less variable reserve estimates than other lines. This is largely due to the coverages having relatively shorter periods of loss emergence. Estimates, however, can still vary due to a number of factors, including interpretations of frequency and severity trends. Severity trends can be impacted by changes in internal claim handling and reserving practices in addition to changes in the external environment. These changes in claim practices increase the uncertainty in the interpretation of case reserve data, which increases the uncertainty in recorded reserve levels.

Life and Health Operations

Bankers Fidelity establishes reserves for future policy benefits to meet projected obligations under policies that are in force as of the statement date. These reserves are calculated to satisfy policy and contract obligations as they are projected to come due.  Reserves for insurance policies are calculated using assumptions for interest rates, mortality rates, disablement rates, benefit utilization rates, and lapse rates. These assumptions vary by the product type, the year the policy was issued, and certain policyholder demographic information.  Changes in assumptions may be made from one issue year to another to reflect actual experience.  Actual future experience that deviates significantly from the assumptions, or actual results that differ significantly from our estimates, could have a materially adverse effect on our liquidity, results of operations, or financial condition.

See Note 6 of Notes to Consolidated Financial Statements for more information on insurance reserves and policyholder funds.

Reinsurance

The Company’s insurance subsidiaries from time to time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect against catastrophic losses. In a reinsurance transaction, an insurance company transfers, or “cedes,” a portion or all of its exposure on insurance policies to a reinsurer. The reinsurer assumes the exposure in return for a portion of the premiums. The ceding of insurance does not legally discharge the insurer from primary liability for the full amount of the policies written by it, and the ceding company will incur a loss if the reinsurer fails to meet its obligations under the reinsurance agreement.

Property and Casualty Operations

American Southern’s basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations. Current limits per occurrence within the reinsurance treaties are as follows: Inland marine and commercial automobile physical damage - $225,000 excess of $125,000 retention; and automobile liability and general liability - excess coverage of $2.0 million less retentions that may vary from $150,000 to $500,000 depending on the account. American Southern maintains a property catastrophe treaty with a $5.5 million limit excess of $500,000 retention. American Southern also issues individual surety bonds with face amounts generally up to $1.5 million, and limited to $5.0 million in aggregate per account, that are not reinsured.

Life and Health Operations

Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention. Maximum retention by Bankers Fidelity on any one individual life insurance policyholder is $200,000. As of December 31, 2023, $8.3 million of the $814.2 million of life insurance in force at Bankers Fidelity was reinsured under a combination of coinsurance and yearly renewable term agreements. Certain prior year reinsurance agreements also remain in force although they no longer provide reinsurance for new business.

Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare Supplement business to General Re Life Corporation. Ceding thresholds are set annually. During 2023, the liability of the reinsurer was 50% of all new Medicare Supplement business issued by the Company on amounts up to a maximum retention of $15.0 million of annualized premium. Accordingly, $0.8 million of the Company’s $1.5 million of new annualized Medicare Supplement premium was ceded.

Competition

Competition for insurance products is based on many factors including premiums charged, terms and conditions of coverage, customer service, financial ratings assigned by independent rating agencies, claims handling, consumer recognition and reputation, perceived financial strength and the experience of the organization in the line of business being written.

Property and Casualty Operations

The businesses in which American Southern engages are highly competitive. The principal areas of competition are pricing and service. Many competing property and casualty companies have been in business longer than American Southern, offer more diversified lines of insurance and have substantially greater financial resources. Management believes, however, that the policies it sells are competitive with those providing similar benefits offered by other insurers doing business in the states in which American Southern operates. American Southern strives to develop strong relationships with its agents and, consequently, believes it is well positioned for new opportunities and programs with those agents.

Life and Health Operations

The life and health insurance business remains highly competitive and includes a large number of insurance companies, many of which are new entrants to the business of providing Medicare supplement and other accident and health insurance products. Bankers Fidelity has established itself as a trusted carrier of choice for its customers providing quality and sustainability for over 65 years.

In order to compete, Bankers Fidelity actively seeks opportunities in niche markets, developing long-term relationships with a select number of independent marketing organizations. Additionally, Bankers Fidelity actively promotes Atlantic American Employee Benefits, the group benefits division, as well as selective association partnerships. It competes with other insurers to attract and retain the allegiance of its independent agents through commission and sales incentive arrangements, accessibility and marketing assistance, lead programs, reputation and market expertise. Bankers Fidelity successfully competes in its chosen markets by establishing relationships with independent agents and providing proprietary marketing initiatives as well as providing outstanding service to policyholders.

Ratings

Ratings are important measures within the insurance industry, and higher ratings are expected to have a favorable impact on the ability of a company to compete in the marketplace. Ratings of insurance companies are not designed for investors and do not constitute recommendations to buy, sell, or hold any security.

Each year A.M. Best Company, Inc. (“A.M. Best”) publishes Best’s Insurance Reports, which includes assessments and ratings of all insurance companies. A.M. Best’s financial strength ratings, which may be revised or revoked at any time, follow a graduated scale of rating categories and notches ranging from A++ (Superior) to F (in liquidation). A.M. Best’s ratings are based on a detailed analysis of the statutory financial condition and operations of an insurance company compared to the industry in general.

American Southern. American Southern Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company, are each, as of the date of this report, rated “A” (Excellent) by A.M. Best.

Bankers Fidelity. Bankers Fidelity Life Insurance Company and its wholly-owned subsidiary, Bankers Fidelity Assurance Company, are each, as of the date of this report, rated “A-” (Excellent) by A.M. Best.

Regulation

Like all domestic insurance companies, the Company’s insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business. Statutes typically delegate regulatory, supervisory, and administrative powers to state insurance commissioners. The method of such regulation varies, but regulation relates generally to the licensing of insurers and their agents, the nature of and limitations on investments, approval of policy forms, reserve requirements, the standards of solvency to be met and maintained, deposits of securities for the benefit of policyholders, and periodic examinations of insurers and trade practices, among other things. The Company’s products generally are subject to rate regulation by state insurance commissions, which require that certain minimum loss ratios be maintained. Certain states also have insurance holding company laws which require registration and periodic reporting by insurance companies controlled by other corporations licensed to transact business within their respective jurisdictions. The Company’s insurance subsidiaries are subject to such legislation and are registered as controlled insurers in those jurisdictions in which such registration is required. Such laws vary from state to state, but typically require periodic disclosure concerning the corporation which controls the registered insurers and all subsidiaries of such corporations, as well as prior notice to, or approval by, the state insurance commissioners of intercorporate transfers of assets (including payments of dividends by the insurance subsidiaries in excess of specified amounts) within the holding company system. The Company believes it is in compliance with all such requirements.

Most states require that rate schedules and other information be filed with the state’s insurance regulatory authority, either directly or through a ratings organization with which the insurer is affiliated. The regulatory authority may disapprove a rate filing if it determines that the rates are inadequate, excessive, or discriminatory. The Company has historically experienced no significant regulatory resistance to its applications for rate adjustments; however, the Company cannot provide any assurance that it will not receive any objections to any applications in the future.

A state may require that acceptable securities be deposited for the protection either of policyholders located in those states or of all policyholders. As of December 31, 2023, the Company was in compliance with all such requirements, and securities with an amortized cost of $14.6 million were on deposit either directly with various state authorities or with third parties pursuant to various custodial agreements on behalf of the Company’s insurance subsidiaries.

Virtually all of the states in which the Company’s insurance subsidiaries are licensed to transact business require participation in their respective guaranty funds designed to cover claims against insolvent insurers. Insurers authorized to transact business in these jurisdictions are generally subject to assessments of up to 4% of annual direct premiums written in that jurisdiction to pay such claims, if any. The likelihood and amount of any future assessments cannot be estimated until an insolvency has occurred.

NAIC Ratios

The National Association of Insurance Commissioners (the “NAIC”) was established to, among other things, provide guidelines to assess the financial strength of insurance companies for state regulatory purposes. The NAIC conducts annual reviews of the financial data of insurance companies primarily through the application of financial ratios prepared on a statutory basis. Annual statements are required to be submitted to state insurance departments to assist them in monitoring insurance companies in their state and to allow such states to determine a desirable range for each such ratio with which companies should comply.

The NAIC developed the Insurance Regulatory Information System (“IRIS”) to help state regulators identify companies that may require regulatory attention. Financial examiners review annual financial statements and the results of key financial ratios based on year-end data with the goal of identifying insurers that appear to require immediate regulatory attention. Each ratio has an established “usual range” of results. A ratio result falling outside the usual range, however, is not necessarily considered adverse; rather, unusual values are used as part of the regulatory early monitoring system. Furthermore, in some years, it may not be unusual for financially sound companies to have several ratios with results outside the usual ranges. Generally, an insurance company may become subject to regulatory scrutiny or, depending on the company’s financial condition, regulatory action if certain of its key IRIS ratios fall outside the usual ranges and the insurer’s financial condition is trending downward.

For the year ended December 31, 2023, Bankers Fidelity Assurance Company had three ratios outside the usual range, primarily as a result of net loss for the year, certain surplus ratios and Non-admitted Assets to Admitted Assets. The net loss at Bankers Fidelity Assurance Company is primarily related to federal income taxes incurred which resulted in a corresponding decrease in surplus levels for the year as well as a growing Deferred Tax Asset which is a Non-admitted.  Atlantic Capital Life Assurance Company had one ratio outside the normal range, Change in Asset Mix.  The Change in Asset Mix was the result of Atlantic Capital Life Assurance Company investing its cash and cash equivalents from prior year into bonds.  Bankers Fidelity Life Insurance Company, American Southern Insurance Company and American Safety Insurance Company had no IRIS ratios outside the usual ranges. Management does not anticipate regulatory action as a result of the 2023 IRIS ratio results for the insurance subsidiaries.

Risk-Based Capital

Risk-based capital (“RBC”) is a metric used by ratings agencies and regulators as an early warning tool to identify weakly capitalized companies for the purpose of initiating further regulatory action. The RBC calculation determines the amount of adjusted capital needed by a company to avoid regulatory action. “Authorized Control Level Risk-Based Capital” (“ACL”) is calculated, and if a company’s adjusted capital is 200% or lower than ACL, it is subject to regulatory action. At December 31, 2023, the Company’s insurance subsidiaries’ RBC levels exceeded the required regulatory levels.

Investments

Investment income represents a significant portion of the Company’s operating and total income. Insurance company investments are subject to state insurance laws and regulations which limit the concentration and types of investments. The following table provides information on the Company’s investments as of the dates indicated.

   
December 31,
 
   
2023
   
2022
 
   
Amount
   
Percent
   
Amount
   
Percent
 
   
(Dollars in thousands)
 
Fixed maturities:
                       
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
50,059
     
21.1
%
 
$
44,412
     
19.4
%
States, municipalities and political subdivisions
   
8,106
     
3.4
     
9,187
     
4.1
 
Public utilities
   
9,530
     
4.0
     
10,284
     
4.5
 
All other corporate bonds
   
150,319
     
63.4
     
144,623
     
63.2
 
Redeemable preferred stock
   
205
     
0.1
     
223
     
0.1
 
Total fixed maturities(1)
   
218,219
     
92.0
     
208,729
     
91.3
 
Equity securities(2)
   
9,413
     
4.0
     
11,562
     
5.0
 
Other invested assets(3)
   
6,381
     
2.8
     
5,386
     
2.4
 
Policy loans(4)
   
1,778
     
0.7
     
1,759
     
0.8
 
Real estate
   
38
     
0.0
     
38
     
0.0
 
Investments in unconsolidated trusts
   
1,238
     
0.5
     
1,238
     
0.5
 
Total investments
 
$
237,067
     
100.0
%
 
$
228,712
     
100.0
%

(1)
Fixed maturities are carried on the balance sheet at estimated fair value. Certain fixed maturities do not have publicly quoted prices, and are carried at estimated fair value as determined by management. Total amortized cost of fixed maturities was $238.6 million as of December 31, 2023 and $236.8 million as of December 31, 2022.
(2)
Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $4.9 million as of December 31, 2023 and 2022.
(3)
Other invested assets are accounted for using the equity method. Total cost of other invested assets was $7.0 million as of December 31, 2023 and $5.6 million as of December 31, 2022.
(4)
Policy loans are valued at unpaid principal balances.

Estimated fair values are determined as discussed in Note 1 of Notes to Consolidated Financial Statements.

Results of the Company’s investment portfolio for periods shown were as follows:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(Dollars in thousands)
 
Average investments(1)
 
$
275,995
   
$
270,636
 
Net investment income
   
10,058
     
9,932
 
Average yield on investments
   
3.6
%
   
3.7
%
Realized investment gains, net
   
70
     
30
 

(1)
Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.

The Company engages a global investment management firm serving the insurance industry to manage the Company’s investment portfolios. Management’s recent investment strategy has been a continued focus on quality and diversification, while improving the overall risk versus return profile of the portfolio.

Human Capital

The Company and its subsidiaries employed 155 people at December 31, 2023. Of the 155 people, 154 were full-time.  We believe that our ability to attract and retain highly motivated and skilled employees with diverse backgrounds and experiences is critical to our continued success.  We also believe the structure of our compensation program is aligned with the interests of our shareholders and serves to reward the performance of our employees.  We monitor and evaluate the effectiveness of our human capital management efforts by seeking formal and informal feedback from our employees, including periodic surveys to obtain opinions on key topics.

We sponsor health and wellness programs in an effort to promote a healthier employee base.  We also offer competitive health and wellbeing benefits to include health, dental, vision, health and flexible savings accounts, disability, life, supplemental and telemedicine.  An Employee Assistance Program (“EAP”) is provided to all full-time employees and their family members at no cost.  The EAP offers confidential telephonic counseling, referral services, legal and financial services and additional tools that offer support and solutions.   Additionally, we offer a 401(k) retirement savings plan with an employer match as well as an annual Safe Harbor Non-Elective contribution.

We strive to provide a work environment that encourages work/life balance.  Options depend on job responsibilities and may include flexible work schedules, paid time off, paid holidays and part-time employment.

We offer tuition reimbursement along with budgeted professional development opportunities in order to foster professional growth and to increase skillsets.

Financial Information by Industry Segment

American Southern and Bankers Fidelity each operate with relative autonomy and each company is evaluated on its individual performance. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. Substantially all revenue other than that in the corporate and other segment is from external sources. For more information on segments, see Note 16 of Notes to Consolidated Financial Statements.

Available Information

The Company files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, amendments to those reports and other information with the Securities and Exchange Commission (the “SEC”). The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including the Company. In addition, as soon as reasonably practicable after such materials are filed with or furnished to the SEC by the Company, the Company makes copies available to the public, free of charge, on or through its web site at www.atlam.com. Neither the Company’s website, nor the information appearing on the website, is included, incorporated into, or a part of, this report.

Executive Officers of the Registrant

The table and information below set forth, for each current executive officer of the Company, his name, age (as of March 1, 2024), positions with the Company and business experience for the past five years, as well as any prior service to the Company.

Name
 
Age
 
Positions with the Company
 
Director or Officer Since
Hilton H. Howell, Jr.
 
61
 
Chairman of the Board, President & CEO
 
1992
J. Ross Franklin
 
46
 
Vice President, CFO and Corporate Secretary
 
2017

Officers are elected annually and serve at the discretion of the board of directors.

Mr. Howell has been President and Chief Executive Officer of the Company since May 1995, and prior thereto served as Executive Vice President of the Company from October 1992 to May 1995. He has been a Director of the Company since October 1992 and effective February 24, 2009, began serving as Chairman of the board of directors. He is also Executive Chairman and Chief Executive Officer of Gray Television, Inc.

Mr. Franklin has been Vice President, Chief Financial Officer and Corporate Secretary of the Company since November 2017, and prior thereto served as Interim Chief Financial Officer from August 2017 to November 2017. Since 2000 he has held various roles of increasing responsibility with Atlantic American and its subsidiaries, previously serving as Vice President, Accounting and Treasurer of Bankers Fidelity since 2009.

Item 1A.
Risk Factors

As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K (a “smaller reporting company”), we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 1B.
Unresolved Staff Comments

Not applicable.

Item 1C.
Cybersecurity

Risk Management and Strategy

The Company’s operations rely on the secure processing, storage, and transmission of confidential and personal identifiable information within various technology platforms. Cybersecurity is a high priority and the Company has made significant investments in its processes and programs designed to prevent, detect, and respond to and recover from cybersecurity threats. We also have processes in place to help ensure compliance with our information security program with respect to our use of third-party service providers.  Such processes and programs are a part of the Company’s overall risk management and compliance programs. The Company continues to enhance its intrusion protection and detection technology, infrastructure and application firewalls, and network monitoring. The Company has also installed advanced endpoint threat protection technology and implemented a mandatory security awareness training program for all employees.  This training is reinforced through periodic simulated phishing tests to assess our employees’ responses to suspicious emails.

The Company uses a sophisticated backup and recovery methodology that supports the replication of data across multiple secure data centers. It also includes a comprehensive disaster recovery plan that is continually tested and designed to help enable us to resume business in the event of a disaster or cybersecurity incident. Through recurring internal and external audits, controls are regularly reviewed, tested, and enhanced to promote best practices. The Company has augmented our information security program through a partnership with a leading global cybersecurity service provider to review and implement additional services such as Security Event Monitoring, Advanced Endpoint Threat Detection, Incident Management Retainer Services, and Strategic Advisory Services focused on Chief Information Security Officer (CISO) duties such as counter-threat intelligence.

Our information security program also includes a cybersecurity Incident Response Plan (“IRP”) that is designed to help protect the integrity, availability and confidentiality of information, prevent loss of service, and comply with legal requirements. The IRP specifies the process for identifying and reporting an incident, initial investigation, risk classification, documentation and communication of incidents, responder procedures, incident reporting, and ongoing training. The IRP also includes processes for determining the materiality of the incident, including the assessment of relevant qualitative and quantitative factors. In the event we identify a potential cybersecurity, privacy or other data security issue, we have defined procedures for responding to such issues, including procedures that address when and how to engage with Company management, our board of directors, third-party advisors and other stakeholders.

The Company also maintains dedicated cyber liability insurance for breach event costs including: post breach event remediation costs; cybercrime coverage (including financial fraud, telecommunications fraud, and phishing attacks); and coverage for system failure, bricking loss, and physical damage. The policy also provides coverage for lost revenue due to a damaged reputation from a cyber breach.

We do not believe any risks from cybersecurity threats have materially affected or are reasonably likely to materially affect the Company or our business strategy, results of operations, or financial condition.

Governance

Our board of directors recognizes the important role of information security and mitigating cybersecurity and other data security threats. Although our full board of directors maintains ultimate responsibility with respect to risk management oversight, our board has delegated oversight of the Company’s information security program and matters of cybersecurity to the Audit Committee of the board of directors. The Company’s senior officers, including its Chief Information Officer, are responsible for the operation of the information security program and regularly communicate with the Audit Committee on the state of the program, risks faced by the Company and the Company’s risk mitigation efforts related thereto.

In addition, the Company’s information technology environment is managed by an experienced team of professionals who follow an extensive set of policies and procedures related to data security. Our data security employees have backgrounds in cybersecurity and data protection, including prior relevant experience in the industry and industry standard certifications.

Item 2.
Properties

Leased Properties. The Company leases space for its principal offices and for some of its insurance operations in an office building located in Atlanta, Georgia under a lease which continues until either party provides written notice of cancellation at least twelve months in advance of the actual termination date. The lease, which commenced on November 1, 2007, provides for rent adjustments on every fifth anniversary of the commencement date. Under the current terms of the lease, the Company occupies approximately 49,586 square feet of office space. In December 2022, Delta Life Insurance Company, the owner of the building, transferred title to the building to 4370 Peachtree LLC. Each of Delta Life Insurance Company and 4370 Peachtree LLC is controlled by an affiliate of the Company.

American Southern leases space for its office in a building located in Atlanta, Georgia. The lease term expires September 30, 2026. Under the terms of the lease, American Southern occupies approximately 17,014 square feet.

The Company believes that its current properties are in good condition, and are sufficient for the operations of its business.

Item 3.
Legal Proceedings

From time to time, the Company and its subsidiaries are, and expect to continue to be, involved in various claims and lawsuits arising in the ordinary course of business, both as a liability insurer defending third-party claims brought against insureds and as an insurer defending coverage claims brought against it, and in various regulatory proceedings in the states in which we do business. The Company accounts for such exposures through the establishment of loss and loss adjustment expense reserves and accrued expenses. We currently do not expect that the ultimate liability, if any, with respect to such ordinary-course claims litigation or regulatory proceedings, after consideration of provisions made for probable losses and costs of defense, will be material to the Company’s consolidated financial condition, although the results of such matters could be material to the consolidated results of operations for any given period.

Item 4.
Mine Safety Disclosures

Not applicable.

PART II

Item 5.
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

The Company’s common stock is listed on the Nasdaq Global Market (Symbol: AAME). As of March 13, 2024, there were 1,286 shareholders of record.

On April 1, 2024, the Company announced that the board of directors declared an annual cash dividend of $0.02 per share of common stock that is payable to shareholders of record at the close of business on April 12, 2024. On August 8, 2023, the Company announced that the board of directors declared an annual cash dividend of $0.02 per share, which was paid on September 12, 2023 to shareholders of record as of August 22, 2023.

The declaration and payment of any future dividends will be at the discretion of the Company’s board of directors and will depend upon the financial condition, capital requirements, and earnings of the Company, as well as any restrictions contained in any agreements by which the Company is bound and other factors as the board of directors may deem relevant. The Company’s primary recurring source of cash for the payment of dividends is dividends from its subsidiaries; although as of December 31, 2023, the Parent held unrestricted cash and investment balances of approximately $4.7 million. Under the insurance code of the state in which each insurance subsidiary is domiciled, dividend payments to the Parent by its insurance subsidiaries are subject to certain limitations, including prior notice to, or approval by, the state insurance commissioners if such dividends are in excess of specified amounts.  In 2024, dividend payments to the Parent by the insurance subsidiaries in excess of $8.8 million would require prior approval.

Issuer Purchases of Equity Securities

On October 31, 2016, the board of directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company's common stock (the "Repurchase Plan") on the open market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.

Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.

The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended December 31, 2023.

Period
 
Total
Number
of Shares
Purchased
   
Average
Price Paid
per Share
   
Total
Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
   
Maximum
Number of Shares
that May Yet be
Purchased Under the
Plans or Programs
 
October 1 – October 31, 2023
   
   
$
     
     
325,129
 
November 1 – November 30, 2023
   
     
     
     
325,129
 
December 1 – December 31, 2023
   
     
     
     
325,129
 
Total
   
   
$
     
         

Stock Performance Graph

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 6.
Reserved

Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following is management’s discussion and analysis of the financial condition and results of operations of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”) for the years ended December 31, 2023 and 2022. This discussion should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere herein.

Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) in the property and casualty insurance industry, and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as “Bankers Fidelity”) in the life and health insurance industry. Each operating company is managed separately, offers different products and is evaluated on its individual performance.

Critical Accounting Policies

The accounting and reporting policies of the Company are in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and, in management’s belief, conform to general practices within the insurance industry. The following is an explanation of the Company’s accounting policies and the resultant estimates considered most significant by management. These accounting policies inherently require significant judgment and assumptions and actual operating results could differ significantly from management’s estimates determined using these policies. Atlantic American does not expect that changes in the estimates determined using these policies will have a material effect on the Company’s financial condition or liquidity, although changes could have a material effect on its consolidated results of operations.

Cash and investments comprised 70% of the Company’s total assets at December 31, 2023. Substantially all of the Company’s investments are in bonds and common and preferred stocks, the values of which are subject to significant market fluctuations. The Company carries all fixed maturities, which includes bonds and redeemable preferred stocks, as available for sale, and equity securities, which includes common and non-redeemable preferred stocks, at their estimated fair values.

Prior to January 1, 2023, the Company applied other than temporary impairment (“OTTI”) guidance for securities in an unrealized loss position. An OTTI was recognized in earnings within realized investment gains (losses) when it was anticipated that the amortized cost would not be recovered. When either: (i) the Company had the intent to sell the security, or (ii) it was more likely than not that the Company would be required to sell the security before recovery, the reduction of amortized cost and the OTTI recognized in earnings was the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions existed, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected was recognized as a reduction of amortized cost and an OTTI in earnings. If the estimated fair value was less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors was recorded in OCI.

On January 1, 2023, the Company adopted accounting standards update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using a modified retrospective approach. Under ASU 2016-13, for securities in an unrealized loss position, a credit loss is recognized in earnings within realized investment gains (losses) when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the reduction of amortized cost and the loss recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as a credit loss by establishing an ACL with a corresponding charge to earnings in realized investment gains (losses). However, the ACL is limited by the amount that the fair value is less than the amortized cost. This limitation is known as the “fair value floor.” If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors (“noncredit loss”) is recorded in OCI.

The Company determines the fair values of certain financial instruments based on the fair value hierarchy established in Accounting Standards Codification (“ASC”) 820-10-20, Fair Value Measurements and Disclosures (“ASC 820-10-20”). The fair values of fixed maturities and equity securities are largely determined by nationally quoted market prices, when available, or independent broker quotations. See Note 2 and Note 3 of Notes to Consolidated Financial Statements with respect to assets and liabilities carried at fair value and information about the inputs used to value those financial instruments, by hierarchy level, in accordance with ASC 820-10-20.

Future policy benefits comprised 34% of the Company’s total liabilities at December 31, 2023. These liabilities relate primarily to life insurance products and are based upon assumed future investment yields, mortality rates, and lapse rates after giving effect to possible risks of adverse deviation. The assumed mortality and lapse rates are based upon the Company’s experience modified as necessary to reflect anticipated trends and are generally established at contract inception. If actual results differ from the initial assumptions, the amount of the Company’s recorded liability could require adjustment.

Unpaid loss and loss adjustment expenses comprised 32% of the Company’s total liabilities at December 31, 2023. This liability includes estimates for: (1) unpaid losses on claims reported prior to December 31, 2023, (2) future development on those reported claims, (3) unpaid ultimate losses on claims incurred prior to December 31, 2023 but not yet reported and (4) unpaid loss adjustment expenses for reported and unreported claims incurred prior to December 31, 2023. Quantification of loss estimates for each of these components involves a significant degree of judgment and estimates may vary, materially, from period to period. Estimated unpaid losses on reported claims are developed based on historical experience with similar claims by the Company. Development on reported claims, estimates of unpaid ultimate losses on claims incurred prior to December 31, 2023 but not yet reported, and estimates of unpaid loss adjustment expenses are developed based on the Company’s historical experience, using actuarial methods to assist in the analysis. The Company’s actuaries develop ranges of estimated development on reported and unreported claims as well as loss adjustment expenses using various methods, including the paid-loss development method, the reported-loss development method, the paid Bornhuetter-Ferguson method and the reported Bornhuetter-Ferguson method. Any single method used to estimate ultimate losses has inherent advantages and disadvantages due to the trends and changes affecting the business environment and the Company’s administrative policies. Further, external factors, such as legislative changes, medical cost inflation, and others may directly or indirectly impact the relative adequacy of liabilities for unpaid losses and loss adjustment expenses. The Company’s approach is to select an estimate of ultimate losses based on comparing results of a variety of reserving methods, as opposed to total reliance on any single method. Unpaid loss and loss adjustment expenses are reviewed periodically for significant lines of business, and when current results differ from the original assumptions used to develop such estimates, the amount of the Company’s recorded liability for unpaid loss and loss adjustment expenses is adjusted. In the event the Company’s actual reported losses in any period are materially in excess of the previously estimated amounts, such losses, to the extent reinsurance coverage does not exist, could have a material adverse effect on the Company’s results of operations.

Receivables are amounts due from reinsurers, insureds and agents, and any sales of investment securities not yet settled, and comprised 12% of the Company’s total assets at December 31, 2023. Insured and agent balances are evaluated periodically for collectibility. Annually, the Company performs an analysis of the creditworthiness of the reinsurers with whom the Company contracts using various data sources. Failure of reinsurers to meet their obligations due to insolvencies, disputes or otherwise could result in uncollectible amounts and losses to the Company. Allowances for uncollectible amounts are established, as and when a loss has been determined probable, against the related receivable. Losses are recognized by the Company when determined on a specific account basis and a general provision for loss is made based on the Company’s historical experience.

Deferred acquisition costs comprised 12% of the Company’s total assets at December 31, 2023. Deferred acquisition costs are commissions, premium taxes, and other incremental direct costs of contract acquisition that results directly from and are essential to the contract transaction(s) and would not have been incurred by the Company had the contract transaction(s) not occurred. The deferred amounts are recorded as an asset on the balance sheet and amortized to expense in a systematic manner. Traditional life insurance and long-duration health insurance deferred policy acquisition costs are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the related liability for policy benefit reserves. Deferred acquisition costs for property and casualty insurance and short-duration health insurance are amortized over the effective period of the related insurance policies. Deferred policy acquisition costs are expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for property and casualty and short-duration health insurance). Assessments of recoverability for property and casualty and short-duration health insurance are extremely sensitive to the estimates of a subsequent year’s projected losses related to the unearned premiums. Projected loss estimates for a current block of business for which unearned premiums remain to be earned may vary significantly from the indicated losses incurred in any previous calendar year.

Deferred income taxes reflect the effect of temporary differences between assets and liabilities that are recognized for financial reporting purposes and the amounts that are recognized for tax purposes. These deferred income taxes are measured by applying currently enacted tax laws and rates. Valuation allowances are recognized to reduce the deferred tax asset to the amount that is deemed more likely than not to be realized. In assessing the likelihood of realization, management considers estimates of future taxable income and tax planning strategies.

Share-based transactions include employee and director share-based compensation awards. The Company determines a grant date fair value based on the price of our publicly-traded common stock and recognize the related compensation expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation awards, the Company recognizes the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

Refer to Note 1 of Notes to Consolidated Financial Statements for details regarding the Company’s significant accounting policies.

Overall Corporate Results

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Revenue
           
Property and Casualty:
           
American Southern
 
$
72,846
   
$
73,949
 
Life and Health:
               
Bankers Fidelity
   
114,199
     
114,015
 
Corporate and Other
   
(252
)
   
(113
)
Total revenue
 
$
186,793
   
$
187,851
 
Income (loss) before income taxes
               
Property and Casualty:
               
American Southern
 
$
5,085
   
$
6,613
 
Life and Health:
               
Bankers Fidelity
   
4,722
     
3,812
 
Corporate and Other
   
(10,372
)
   
(8,329
)
Income (loss) before income taxes
 
$
(565
)
 
$
2,096
 
Net income (loss)
 
$
(171
)
 
$
1,525
 

Management also considers and evaluates performance by analyzing the non-GAAP measure operating income or loss, and believes it is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as income tax expense, which is subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operational results (such as any realized or unrealized investment gains or losses, which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization).

A reconciliation of net income, the most directly comparable GAAP measure, to operating income is as follows:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Reconciliation of Non-GAAP Financial Measure
           
             
Net income (loss)
 
$
(171
)
 
$
1,525
 
Income tax expense (benefit)
   
(394
)
   
571
 
Realized investment gains, net
   
(70
)
   
(30
)
Unrealized losses on equity securities, net
   
2,177
     
7,562
 
Non-GAAP operating income
 
$
1,542
   
$
9,628
 

On a consolidated basis, the Company had net loss of $0.2 million, or $0.03 per diluted share, in 2023, compared to net income of $1.5 million, or $0.06 per diluted share, in 2022. The decrease in net income was primarily due to a decrease in earned premiums, as well as an increase in losses and expenses as a percentage of premiums.  Also contributing to the decrease in net income is an increase in debt service costs due to rising interest rates.  Partially offsetting this decrease was a decline in unrealized losses on equity securities.

Total revenue was $186.8 million in 2023 as compared to $187.9 million in 2022. Premium revenue decreased to $178.8 million in 2023 from $185.4 million in 2022. The decrease in premium revenue was primarily attributable to a decrease in Medicare supplement insurance premiums within the life and health operations.  Also contributing to the decrease in premium revenue was a decrease in earned premiums in the automobile physical damage line of business due to a reduction in the number of programs.  Partially offsetting the decrease in premium revenue was an increase in earned premiums in the automobile liability line of business due mainly to rate increases and a retrospective premium adjustment in a governmental program.

Operating income was $1.5 million in 2023 as compared to $9.6 million in 2022. The decrease in operating income was primarily due to a decline in premium revenue and an increase in losses and expenses as a percentage of premiums, as discussed above.  Partially offsetting the decline in operating income was more favorable loss experience in the life and health operations, resulting from improved rate adequacy and a decrease in the number of incurred claims within the Medicare supplement line of business.

A more detailed analysis of the operating companies and other corporate activities follows.

UNDERWRITING RESULTS
American Southern

The following table summarizes, for the periods indicated, American Southern’s premiums, losses, expenses and underwriting ratios:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(Dollars in thousands)
 
Gross written premiums
 
$
77,567
   
$
79,218
 
Ceded premiums
   
(5,902
)
   
(6,547
)
Net written premiums
 
$
71,665
   
$
72,671
 
Net earned premiums
 
$
68,443
   
$
70,276
 
Insurance benefits and losses incurred
   
51,015
     
47,175
 
Commissions and underwriting expenses
   
16,746
     
20,161
 
Underwriting income
 
$
682
   
$
2,940
 
Loss ratio
   
74.5
%
   
67.1
%
Expense ratio
   
24.5
     
28.7
 
Combined ratio
   
99.0
%
   
95.8
%

Gross written premiums at American Southern decreased $1.7 million, or 2.1%, during 2023 as compared to 2022. The decrease in gross written premiums was primarily attributable to the decrease in premiums written in the automobile physical damage line of business due to a reduction in the number of agencies. Partially offsetting the decrease in gross written premiums was an increase in premiums written in the automobile liability line of business resulting from new business, rate increases, and retrospective premium adjustments.

Ceded premiums decreased $0.6 million, or 9.9%, during 2023 as compared to 2022. American Southern’s ceded premiums are typically determined as a percentage of earned premiums and generally increase or decrease as earned premiums increase or decrease.  The decrease in ceded premiums was primarily attributable to the decrease in earned premiums in the automobile physical damage line of business, as well as decreased ceding rates due to increased retention.

The following table summarizes, for the periods indicated, American Southern’s net earned premiums by line of business:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Automobile liability
 
$
38,821
   
$
33,981
 
Automobile physical damage
   
15,046
     
21,069
 
General liability
   
5,758
     
5,871
 
Surety
   
6,303
     
6,039
 
Other lines
   
2,515
     
3,316
 
Total
 
$
68,443
   
$
70,276
 

Net earned premiums decreased $1.8 million, or 2.6%, during 2023 as compared to 2022. The decrease in net earned premiums was primarily attributable to a decrease in earned premiums in the automobile physical damage line of business due to a reduction in the number of agencies as previously mentioned. Also contributing to the decrease was a decline in earned premiums in the inland marine line of business resulting from reduced cargo production. Partially offsetting the decrease in net earned premiums was an increase in earned premiums in the automobile liability line of business due mainly to rate increases and a retrospective premium adjustment in a governmental program. Premiums are earned ratably over their respective policy terms and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.

The performance of a property and casualty insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).

Insurance benefits incurred at American Southern increased $3.8 million, or 8.1%, during 2023 as compared to 2022. As a percentage of premiums, insurance benefits and losses incurred were 74.5% in 2023 as compared to 67.1% in 2022. The increase in the loss ratio was mainly due to overall inflation on claims and increased severity of losses reported from certain governmental programs within the automobile liability line of business. Also contributing to the increase in the loss ratio were increased losses in the general liability line of business from artisan contractor business. Partially offsetting the increase in the loss ratio was a decrease in losses related to the automobile physical damage line of business due to a decrease in exposure.

Commissions and underwriting expenses decreased $3.4 million, or 16.9%, during 2023 as compared to 2022. As a percentage of premiums, these expenses were 24.5% in 2023 as compared to 28.7% in 2022. The decrease in the expense ratio was primarily due to the decrease in fixed and variable commissions.  Fixed commissions decreased as a result of the decline in written premiums during 2023.  Also contributing to the decrease in expense ratio was American Southern’s use of a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases, commissions and underwriting expenses will generally increase, and conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease.  In 2023, variable commissions at American Southern decreased $1.4 million as compared to 2022 due to an increase in loss ratios from certain accounts subject to variable commissions.

Bankers Fidelity

The following summarizes, for the periods indicated, Bankers Fidelity’s premiums, losses and expenses:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(Dollars in thousands)
 
Medicare supplement
 
$
133,343
   
$
148,747
 
Other health products
   
14,373
     
12,389
 
Life insurance
   
18,659
     
15,867
 
Gross earned premiums
   
166,375
     
177,003
 
Ceded premiums
   
(55,993
)
   
(61,839
)
Net earned premiums
   
110,382
     
115,164
 
Insurance benefits and losses incurred
   
71,485
     
76,281
 
Commissions and underwriting expenses
   
37,992
     
33,922
 
Total expenses
   
109,477
     
110,203
 
Underwriting income
 
$
905
   
$
4,961
 
Loss ratio
   
64.8
%
   
66.2
%
Expense ratio
   
34.4
     
29.5
 
Combined ratio
   
99.2
%
   
95.7
%

Net earned premium revenue at Bankers Fidelity decreased $4.8 million, or 4.2%, during 2023 as compared to 2022. Gross earned premiums from the Medicare supplement line of business decreased $15.4 million, or 10.4 %, in 2023 as compared to 2022, due primarily to non-renewals exceeding the level of new business writings as the existing block of business has incurred rate increases. Other health product premiums increased $2.0 million, or 16.0%, during 2023 as compared to 2022, primarily as a result of new sales of the company’s group health and individual cancer products. Gross earned premiums from the life insurance line of business increased $2.8 million, or 17.6%, in 2023 from 2022 due to an increase in the group life product premiums. Partially offsetting this increase was a decrease in individual life products premium, resulting from the redemption and settlement of existing individual life policy obligations exceeding the level of new individual life sales. Premiums ceded decreased $5.8 million, or 9.5%, in 2023 from 2022. The decrease in ceded premiums was due to a decrease in Medicare supplement premiums subject to reinsurance.

Insurance benefits and losses incurred decreased $4.8 million, or 6.3%, during 2023 as compared to 2022. As a percentage of premiums, benefits and losses were 64.8% in 2023 as compared to 66.2% in 2022. The decrease in the loss ratio was primarily due to improved rate adequacy and a decrease in the number of incurred claims within the Medicare supplement line of business. Also contributing to the decrease in loss ratio was an improvement in the other health lines profitability.  These decreases were offset by higher incurred claims on our life lines of business.

Commissions and underwriting expenses increased $4.1 million, or 12.0%, during 2023 as compared to 2022. As a percentage of earned premiums, these expenses were 34.4% in 2023 as compared to 29.5% in 2022. The increase in the expense ratio was primarily due to an increase in administrative costs related to growth in the group and individual health lines of business, coupled with increased Medicare supplement servicing costs.

Net Investment Income and Realized Gains

Investment income increased $0.1 million, or 1.3%, in 2023 as compared to 2022.  The increase in investment income was primarily attributable to an increase in investment income related to fixed maturities and equity securities.  Partially offsetting this increase was a decrease in the equity in earnings from investments in the Company's limited partnerships and limited liability companies of $0.6 million.

The Company had net realized investment gains of $0.1 million in 2023 as compared to net realized investment gains of $0.03 million in 2022. The net realized investment gains in 2023 and 2022 were primarily attributable to gains from the sale of fixed maturities. Management continually evaluates the Company’s investment portfolio and, as may be determined to be appropriate, makes adjustments for impairments and/or will divest investments. See Note 2 of Notes to Consolidated Financial Statements.

Unrealized Losses on Equity Securities, Net

Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period. The Company recognized net unrealized losses on equity securities of $2.2 million and $7.6 million during the years ended December 2023 and 2022, respectively. Changes in unrealized gains on equity securities for the applicable periods are primarily the result of fluctuations in the market value of certain of the Company’s equity securities.

Interest Expense

Interest expense increased $1.3 million, or 67.5%, in 2023 as compared to 2022. Changes in interest expense were primarily due to changes in the Term Secured Overnight Financing Rate (“SOFR”) published by CME Group Benchmark Administration Limited (“CME”), as the interest rates on the Company’s outstanding junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) and the revolving credit facility are directly related to SOFR. As expected, discontinuation of London Interbank Offered Rate (“LIBOR”) occurred on June 30, 2023 and affected the rates used in the Company’s credit arrangements after that date. The U.S. Congress enacted the Adjustable Interest Rate LIBOR Act (the "LIBOR Act") to address LIBOR’s cessation and the Board of Governors of the Federal Reserve System issued regulations, 12 C.F.R. Part 253, “Regulations Implementing the Adjustable Interest Rate LIBOR Act (Regulation ZZ),” which relate to the LIBOR transition.

Income Taxes

The primary difference between the effective tax rate and the federal statutory income tax rate for 2023 resulted from the adjustment for prior years’ estimates to actual of $0.3 million in the year ended December 31, 2023, which included the return to provision adjustment that is generally updated at the completion of the third quarter of each fiscal year and an adjustment for partnership valuation. Also contributing to the differences between the effective tax rate and the federal statutory income tax rate was a permanent difference related to meals and entertainment.

The primary differences between the effective tax rate and the federal statutory income tax rate for 2022 resulted from a permanent difference related to penalties and fines incurred of $0.1 million.  Also contributing to differences between the effective tax rate and the federal statutory income tax rate were the adjustment for prior years’ estimates to actual that are generally updated at the completion of the third quarter of each fiscal year and were $0.1 million in the year ended December 31, 2022. Other contributing factors to the differences between the effective tax rate and the federal statutory income tax rate were permanent differences related to meals and entertainment and the dividends-received deduction (“DRD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income.

Liquidity and Capital Resources

The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current and expected patterns of claim frequency and severity may change from period to period, but generally are expected to continue within historical ranges. The Company’s primary sources of cash are written premiums, investment income and proceeds from the sale and maturity of its invested assets, as well as borrowings from time to time under our revolving credit facility.  The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.

Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company’s board of directors from time to time. At December 31, 2023, the Parent had approximately $4.7 million of unrestricted cash and investments.

Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before recognizing realized investment gains of the individual insurance subsidiaries. At December 31, 2023, the Parent’s insurance subsidiaries had an aggregate statutory surplus of $90.1 million. Dividends were paid to Atlantic American by its subsidiaries totaling $8.4 million and $7.2 million in 2023 and 2022, respectively.

The Parent provides certain administrative, purchasing and other services to each of its subsidiaries. The amount charged to and paid by the subsidiaries for these services was $8.7 million and $7.6 million in 2023 and 2022, respectively. In addition, the Parent has a formal tax-sharing agreement with each of its insurance subsidiaries. A net total of $4.0 million and $3.9 million were paid to the Parent under the tax sharing agreement in 2023 and 2022, respectively.

The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of 3-month CME Term SOFR plus applicable tenor spread of 0.26161 percent plus an applicable margin. The margin ranges from 4.00% to 4.10%. At December 31, 2023, the effective interest rate was 9.69%. The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust’s obligations with respect to the trust preferred securities. Subject to certain exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. The Company has not made such an election.

The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from existing or potential future financing arrangements.

At December 31, 2023, the Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends on the Series D Preferred Stock of $17.7 thousand at December 31, 2023 and 2022. During each of 2023 and 2022, the Company paid Series D Preferred Stock dividends of $0.4 million.

Bankers Fidelity Life Insurance Company (''BFLIC") is a member of the Federal Home Loan Bank of Atlanta ("FHLB"), for the primary purpose of enhancing financial flexibility. As a member, BFLIC can obtain access to low-cost funding and also receive dividends on FHLB stock. The membership arrangement provides for credit availability of five percent of statutory admitted assets, or approximately $8.0 million, as of December 31, 2023. Additional FHLB stock purchases may be required based upon the amount of funds borrowed from the FHLB.  As of December 31, 2023, BFLIC has pledged bonds having an amortized cost of $9.6 million to the FHLB.  BFLIC may be required to post additional acceptable forms of collateral for any borrowings that it makes in the future from the FHLB.  As of December 31, 2023, BFLIC does not have any outstanding borrowings from the FHLB.

On May 12, 2021, the Company entered into a Revolving Credit Agreement (the “Credit Agreement”) with Truist Bank as the lender (the “Lender”). The Credit Agreement provides for an unsecured $10.0 million revolving credit facility that matures on April 12, 2024. Under the Credit Agreement, the Company paid interest on the unpaid principal balance of outstanding revolving loans at 1-month SOFR plus a spread adjustment of 0.11448% plus 2.00%, subject to a SOFR floor rate of 1.00%.

The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35% of the Company’s consolidated capitalization at any time. The Credit Agreement also contains customary representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the Lender may, among other things, declare all obligations under the Credit Agreement immediately due and payable and terminate the revolving commitments.  As of December 31, 2023, the Company had outstanding borrowings of $3.0 million under the Credit Agreement.

Cash and cash equivalents decreased from $28.9 million at December 31, 2022 to $28.3 million at December 31, 2023. The decrease in cash and cash equivalents during 2023 was primarily attributable to a decrease in  net cash used in investing activities of $3.4 million primarily as a result of investment purchases exceeding investment sales and maturity of securities. Partially offsetting the decrease in cash and cash equivalents was an increase in net cash provided by operating activities of $2.6 million.

The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from financial institutions, will enable the Company to meet its liquidity requirements for the next 12 months and thereafter for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company’s liquidity, capital resources or operations.

New Accounting Pronouncements

See “Recently Issued Accounting Standards” in Note 1 of Notes to Consolidated Financial Statements.

Impact of Inflation

Insurance premiums are established before the amount of losses and loss adjustment expenses, or the extent to which inflation may affect such losses and expenses, are known. Consequently, in establishing its premiums, the Company attempts to anticipate the potential impact of inflation. If, for competitive reasons, premiums cannot be increased to anticipate inflation, this cost would be absorbed by the Company. Inflation also affects the rate of investment return on the Company’s investment portfolio with a corresponding effect on investment income. During 2023, inflation was a factor in increased loss experience within the Company’s automobile liability line of business.

Item 7A.
Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.


Item 8.
Financial Statements and Supplementary Data

INDEX TO FINANCIAL STATEMENTS

 
Page
ATLANTIC AMERICAN CORPORATION
 
   
Report of Independent Registered Public Accounting Firm (FORVIS, LLP), Atlanta, Georgia, PCAOB Firm ID No. 686)
25
 
Consolidated Balance Sheets as of December 31, 2023 and 2022
28


Consolidated Statements of Operations for the years ended December 31, 2023 and 2022
29


Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023 and 2022
30


Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2023 and 2022
31


Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022
32


Notes to Consolidated Financial Statements
33

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
Atlantic American Corporation
Atlanta, GA

Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Atlantic American Corporation and subsidiaries (the “Company”) as of December 31, 2023, and 2022, and the related consolidated statements of operations, comprehensive loss, shareholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes and schedules (collectively, referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America (US GAAP).

Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits.

We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
 
Valuation of Insurance Reserves for Losses and Claims (Claim Reserves)
As reflected on the consolidated balance sheet and discussed in Note 6 to the financial statements, the Company’s insurance reserves for losses and claims (claim reserves), were $87.5 million as of December 31, 2023. The Company’s claim reserves relate primarily to its property casualty lines of business and Medicare supplement business. The process of establishing claim reserves requires the use of estimates and judgments based on circumstances underlying the insured loss at the date of accrual. Management’s judgments include claims adjusters’ evaluations for unpaid claims reported prior to the close of the accounting period, estimates of incurred but not reported (IBNR) claims based on past experience and estimates of loss adjustment expenses.
 
The principal considerations for our determination that the valuation of claim reserves is a critical audit matter are the high degree of judgment and subjectivity in auditing the actuarial methods and assumptions used in the valuation process, including assumptions around expected loss ratios and reported and paid loss emergence patterns.
 
Addressing the matter involved performing the following audit procedures, among others:
 

Involving our actuarial specialists to assist in our procedures in:
 

o
Evaluating the appropriateness of management’s actuarial reserving methodologies and assumptions;
 

o
Evaluating management’s hindsight analyses;
 

o
Comparing management’s carried reserve to the range calculated by management’s specialist for property casualty claim reserves;
 

Testing the completeness and accuracy of data provided by management that served as the basis for the actuarial analyses on a sample basis; and
 

Evaluating movement of the Company’s recorded property casualty claim reserves within the Company’s estimated reserve range year over year.
 
Valuation of Insurance Reserves for Future Policy Benefits (Policy Reserves)
As reflected on the consolidated balance sheet and discussed in Note 6 to the financial statements, the Company’s insurance reserves for future policy benefits (policy reserves) were $92.5 million as of December 31, 2023. Policy reserves are related to life and health insurance policies and are based upon significant assumptions including future investment yields, mortality rates, withdrawal rates and expenses after giving effect to possible risks of unexpected claim experience. These assumptions are based on historical experience modified as necessary to reflect anticipated trends and are generally established at contract inception.

The principal considerations for our determination that the valuation of policy reserves is a critical audit matter are the high degree of judgment required to assess certain assumptions that impact policy reserves and the complexity of the actuarial calculations.
 
Addressing the matter involved performing the following audit procedures, among others:
 

Involving our actuarial specialists to assist in our procedures in:
 

o
Evaluating whether the methodology applied by management is consistent in the aggregate with the methodology compliant with US GAAP;
 

o
Assessing the significant assumptions used by management for new insurance contracts issued during the current year by comparing the significant assumptions noted above to historical experience, observable market data or management’s estimates of prospective changes to these assumptions;
 

o
Reviewing benefit reserve replication workbooks prepared by management for a sample of contracts; and
 

o
Evaluating management’s loss recognition testing of aggregate reserve sufficiency.
 

Testing the completeness and accuracy of data used by management in developing assumptions on a sample basis.
 
We have served as the Company’s auditor since 2018.

/s/ FORVIS, LLP

Atlanta, GA
April 1, 2024


ATLANTIC AMERICAN CORPORATION
CONSOLIDATED BALANCE SHEETS

   
December 31,
 
   
2023
   
2022
 
   
(In thousands,
except share and per
share data)
 
ASSETS
           
Cash and cash equivalents
 
$
28,301
   
$
28,863
 
Investments:
               
Fixed maturities, available-for-sale, at fair value (amortized cost: $238,626 and $236,766; no allowance for credit losses)
   
218,219
     
208,729
 
Equity securities, at fair value (cost: $4,936 and $4,907)
   
9,413
     
11,562
 
Other invested assets (cost: $6,982 and $5,628)
   
6,381
     
5,386
 
Policy loans
   
1,778
     
1,759
 
Real estate
   
38
     
38
 
Investment in unconsolidated trusts
   
1,238
     
1,238
 
Total investments
   
237,067
     
228,712
 
Receivables:
               
Reinsurance (net of allowance for uncollectible reinsurance of $61 and $0)
   
21,103
     
25,913
 
Insurance premiums and other (net of allowance for expected credit losses $217 and net of allowance for doubtful accounts $177)
   
23,690
     
15,386
 
Deferred income taxes, net
   
15,682
     
14,163
 
Deferred acquisition costs
   
43,850
     
42,281
 
Other assets
   
9,028
     
9,202
 
Intangibles
   
2,544
     
2,544
 
Total assets
 
$
381,265
   
$
367,064
 
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Insurance reserves and policyholder funds
               
Future policy benefits
 
$
92,495
   
$
85,564
 
Unearned premiums
   
31,317
     
28,348
 
Losses and claims
   
87,478
     
87,484
 
Other policy liabilities
   
1,132
     
1,255
 
Total insurance reserves and policyholder funds
   
212,422
     
202,651
 
Accounts payable and accrued expenses
   
24,811
     
26,473
 
Revolving credit facility
    3,019       2,009  
Junior subordinated debenture obligations, net
   
33,738
     
33,738
 
Total liabilities
   
273,990
     
264,871
 
Commitments and contingencies (Note 17)    
     
 
Shareholders’ equity:
               
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value
   
55
     
55
 
Common stock, $1 par, 50,000,000 shares authorized; 22,400,894 shares issued; 20,402,288 and 20,407,229 shares outstanding as of 2023 and 2022, respectively
   
22,401
     
22,401
 
Additional paid-in capital
   
57,425
     
57,425
 
Retained earnings
   
50,929
     
51,982
 
Accumulated other comprehensive loss
   
(16,121
)
   
(22,149
)
Unearned stock grant compensation
   
(13
)
   
(132
)
Treasury stock, at cost, 1,998,606 and 1,993,665 shares as of 2023 and 2022, respectively
   
(7,401
)
   
(7,389
)
Total shareholders’ equity
   
107,275
     
102,193
 
Total liabilities and shareholders’ equity
 
$
381,265
   
$
367,064
 

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands,
except per share data)
 
Revenue:
           
Insurance premiums, net
 
$
178,825
   
$
185,440
 
Net investment income
   
10,058
     
9,932
 
Realized investment gains, net
   
70
     
30
 
Unrealized losses on equity securities, net
   
(2,177
)
   
(7,562
)
Other income
   
17
     
11
 
Total revenue
   
186,793
     
187,851
 
                 
Benefits and expenses:
               
Insurance benefits and losses incurred
   
122,500
     
123,456
 
Commissions and underwriting expenses
   
46,124
     
46,713
 
Interest expense
   
3,269
     
1,952
 
Other expense
   
15,465
     
13,634
 
Total benefits and expenses
   
187,358
     
185,755
 
                 
Income (loss) before income taxes
   
(565
)
   
2,096
 
Income tax expense (benefit)
   
(394
)
   
571
 
Net income (loss)
   
(171
)
   
1,525
 
Preferred stock dividends
   
(399
)
   
(399
)
Net income (loss) applicable to common shareholders
 
$
(570
)
 
$
1,126
 
Earnings (loss) per common share (basic and diluted)
   
(0.03
)
   
0.06
 

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Net income (loss)
 
$
(171
)
 
$
1,525
 
Other comprehensive gain (loss):
               
Available-for-sale fixed maturity securities:
               
Gross unrealized holding gain (loss) arising in the period
   
7,700
     
(50,377
)
Related income tax effect
   
(1,617
)
   
10,579
 
Subtotal
   
6,083
     
(39,798
)
                 
Less: reclassification adjustment for net realized gains included in net income
   
(70
)
   
(49
)
Related income tax effect
   
15
     
10
 
Subtotal
   
(55
)
   
(39
)
                 
Total other comprehensive income (loss), net of tax
   
6,028
     
(39,837
)
Total comprehensive income (loss)
 
$
5,857
   
$
(38,312
)

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

   
Year Ended December 31,
 
(In thousands, except share and per share data)
 
2023
   
2022
 
Preferred stock:
           
Balance, beginning of year
 
$
55
   
$
55
 
Balance, end of year
   
55
     
55
 
Common stock:
               
Balance, beginning of year
   
22,401
     
22,401
 
Balance, end of year
   
22,401
     
22,401
 
Additional paid-in capital:
               
Balance, beginning of year
   
57,425
     
57,441
 
Restricted stock grants, net of forfeitures
   
     
(16
)
Balance, end of year
   
57,425
     
57,425
 
Retained earnings:
               
Balance, beginning of year
   
51,982
     
51,264
 
  Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
    (75 )      
Net income (loss)
   
(171
)
   
1,525
 
Dividends on common stock
   
(408
)
   
(408
)
Dividends accrued on preferred stock
   
(399
)
   
(399
)
Balance, end of year
   
50,929
     
51,982
 
Accumulated other comprehensive income (loss):
               
Balance, beginning of year
   
(22,149
)
   
17,688
 
Other comprehensive income (loss), net of tax
   
6,028
     
(39,837
)
Balance, end of year
   
(16,121
)
   
(22,149
)
Unearned stock grant compensation:
               
Balance, beginning of year
   
(132
)
   
(73
)
Restricted stock grants, net of forfeitures
   
     
(193
)
Amortization of unearned compensation
   
119
     
134
 
Balance, end of year
   
(13
)
   
(132
)
Treasury stock:
               
Balance, beginning of year
   
(7,389
)
   
(7,490
)
Restricted stock grants, net of forfeitures
   
     
209
 
Net shares acquired related to employee share-based compensation plans
   
(12
)
   
(108
)
Balance, end of year
   
(7,401
)
   
(7,389
)
                 
Total shareholders’ equity
 
$
107,275
   
$
102,193
 
Dividends declared on common stock per share
 
$
0.02
   
$
0.02
 
                 
Common shares outstanding:
               
Balance, beginning of year
    20,407,229       20,378,576  
Net shares acquired under employee share-based compensation plans
    (4,941 )     (36,347 )
Restricted stock grants, net of forfeitures
          65,000  
Balance, end of year
    20,402,288       20,407,229  

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Cash flows from operating activities:
           
Net Income (loss)
 
$
(171
)
 
$
1,525
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Amortization of deferred acquisition costs
   
16,440
     
19,445
 
Acquisition costs deferred
   
(18,009
)
   
(23,028
)
Realized investment gains, net
   
(70
)
   
(30
)
Unrealized losses on equity securities, net
   
2,177
     
7,562
 
Losses (earnings) from equity method investees
    360       (241 )
Compensation expense related to share awards
   
119
     
134
 
Provision for credit losses
    26        
Depreciation and amortization
   
652
     
890
 
Deferred income tax benefit
   
(3,121
)
   
(1,819
)
(Increase) decrease in receivables, net
   
(3,520
)
   
1,076
 
Increase in insurance reserves and policyholder funds
   
9,771
     
854
 
(Decrease) increase in accounts payable and accrued expenses
   
(1,662
)
   
1,008
 
Other, net
   
(370
)
   
(923
)
Net cash provided by operating activities
   
2,622
     
6,453
 
                 
Cash flows from investing activities:
               
Proceeds from investments sold
   
5,044
     
3,902
 
Proceeds from investments matured, called or redeemed
   
9,744
     
9,806
 
Investments purchased
   
(18,073
)
   
(17,010
)
Additions to property and equipment
   
(80
)
   
(126
)
Net cash used in investing activities
   
(3,365
)
   
(3,428
)
                 
Cash flows from financing activities:
               
Payment of dividends on Series D preferred stock
   
(399
)
   
(399
)
Payment of dividends on common stock
   
(408
)
   
(408
)
Treasury stock acquired — net employee share-based compensation
   
(12
)
   
(108
)
Proceeds from revolving credit facility, net
    1,000       2,000  
Net cash provided by financing activities
   
181
     
1,085
 
                 
Net (decrease) increase in cash
   
(562
)
   
4,110
 
Cash and cash equivalents at beginning of year
   
28,863
     
24,753
 
Cash and cash equivalents at end of year
 
$
28,301
   
$
28,863
 
                 
Supplemental cash flow information:
               
Cash paid for interest
 
$
3,227
   
$
1,794
 
Cash paid for income taxes
 
$
2,582
   
$
2,764
 

See the accompanying notes to the consolidated financial statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands)

Note 1.
Summary of Significant Accounting Policies

Principles of Consolidation


The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) which, for insurance companies, differ in some respects from the statutory accounting practices prescribed or permitted by regulatory authorities. These financial statements include the accounts of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation. Operating results achieved in any historical period are not necessarily indicative of results to be expected in any future period.


At December 31, 2023, the Parent owned five insurance subsidiaries, Bankers Fidelity Life Insurance Company and its wholly-owned subsidiaries, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as “Bankers Fidelity”), and American Southern Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company.  American Southern Insurance Company also wholly-owned three non-insurance subsidiaries, Premier Adjusting and Claim Services, Inc., Automobile Safety Management, Inc. and Automated Systems of Georgia, Inc. (together with American Southern Insurance Company and American Safety Insurance Company known as “American Southern”). In addition, the Parent owned one non-insurance subsidiary, xCalibre Risk Services, Inc. The Parent has issued a guarantee of all liabilities of Bankers Fidelity.

Premium Revenue and Cost Recognition


Life insurance premiums are recognized as revenue when due; accident and health insurance premiums are recognized as revenue over the premium paying period and property and casualty insurance premiums are recognized as revenue over the period of the contract in proportion to the amount of insurance protection provided. Losses, benefits and expenses are accrued as incurred and are associated with premiums as they are earned so as to result in recognition of profits over the lives of the contracts. For traditional life insurance and long-duration health insurance, this association is accomplished by the provision of a future policy benefits reserve and the deferral and subsequent amortization of the costs of acquiring business, which are referred to as “deferred policy acquisition costs” (principally commissions, premium taxes, and other incremental direct costs of issuing policies). Deferred policy acquisition costs (“DAC”) are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the future policy benefits reserve. The Company provides for insurance benefits and losses on accident, health, and property-casualty claims based upon estimates of projected ultimate losses. DAC for property and casualty insurance and short-duration health insurance is amortized over the effective period of the related insurance policies. Contingent commissions, if contractually applicable, are ultimately payable to agents based on the underlying profitability of a particular insurance contract or a group of insurance contracts, and are periodically evaluated and accrued as earned. In periods in which revisions are made to the estimated loss reserves related to the particular insurance contract or group of insurance contracts subject to such commissions, corresponding adjustments are also made to the related accruals. DAC is expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for property and casualty and short-duration health insurance).



Insurance Premiums and Other Receivables



Receivables amounts due from reinsurers, insureds and agents are evaluated periodically for collectibility. Allowances for expected credit losses are established, as and when a loss has been determined probable, against the related receivable. An allowance for expected credit loss is recognized by the Company when determined on a specific account basis and a general provision for loss is made based on the Company’s historical and expected experience.

Intangibles


Intangibles consist of goodwill and other indefinite-lived intangible assets. Goodwill represents the excess of cost over the fair value of net assets acquired and is not amortized. Other indefinite-lived intangibles represent the value of licenses and are not amortized. The Company periodically reviews its goodwill and other indefinite-lived intangibles to determine if any adverse conditions exist that could indicate impairment. Conditions that could trigger impairment include, but are not limited to, a significant change in business climate that could affect the value of the related asset, an adverse action, or an assessment by a regulator. No impairment of the Company’s recorded intangibles was identified during any of the periods presented.
Investments


The Company’s investments in fixed maturities, which include bonds and redeemable preferred stocks, are classified as “available-for-sale” and, accordingly, are carried at fair value with the after-tax difference from amortized cost, less allowance for credit losses (“ACL”), as adjusted if applicable, reflected in shareholders’ equity as a component of accumulated other comprehensive income or loss. The Company’s equity securities, which include common and non-redeemable preferred stocks, are carried at fair value with changes in fair value reported in net income. The fair values of fixed maturities and equity securities are largely determined from publicly quoted market prices, when available, or independent broker quotations. Values that are not determined using quoted market prices inherently involve a greater degree of judgment and uncertainty and therefore ultimately greater price volatility than the value of securities with publicly quoted market prices.


Prior to January 1, 2023, the Company applied other than temporary impairment (“OTTI”) guidance for securities in an unrealized loss position. An OTTI was recognized in earnings within realized investment gains (losses) when it was anticipated that the amortized cost would not be recovered. When either: (i) the Company had the intent to sell the security, or (ii) it was more likely than not that the Company would be required to sell the security before recovery, the reduction of amortized cost and the OTTI recognized in earnings was the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions existed, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected was recognized as a reduction of amortized cost and an OTTI in earnings. If the estimated fair value was less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors was recorded in OCI.


On January 1, 2023, the Company adopted accounting standards update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using a modified retrospective approach. Under ASU 2016-13, for securities in an unrealized loss position, a credit loss is recognized in earnings within realized investment gains (losses) when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the reduction of amortized cost and the loss recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as a credit loss by establishing an ACL with a corresponding charge to earnings in realized investment gains (losses). However, the ACL is limited by the amount that the fair value is less than the amortized cost. This limitation is known as the “fair value floor.” If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors (“noncredit loss”) is recorded in OCI.


Policy loans are carried at unpaid principal balance and are fully collateralized by the cash surrender value of the underlying insurance contract.  Real estate is carried at historical cost and is evaluated for impairment when circumstances would indicate that fair value may be less than carrying value.


The Company holds passive interests in a number of entities that are considered to be variable interest entities (“VIEs”) under GAAP guidance. The Company’s VIE interests principally consist of interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns, which are included in other invested assets on the balance sheet and are accounted for using the equity method. The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not consolidated these VIEs. Also included in the Company’s VIEs are investments in unconsolidated trusts, which are presented on the balance sheet and carried at cost. The Company’s involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other financial support to or on behalf of the VIE. The Company reviews its investments in other invested assets for impairment no less frequently than quarterly and monitors the performance throughout the year.  If the Company becomes aware of an impairment of an other invested asset at the balance sheet date, it will recognize an impairment by recording a reduction in the carrying value of the other invested asset with a corresponding charge to net investment income.



Premiums and discounts related to investments are amortized or accreted over the life of the related investment as an adjustment to yield using the effective interest method. Dividends and interest income are recognized when earned or declared. The cost of securities sold is based on specific identification. Unrealized gains (losses) in the value of fixed maturities are accounted for as a direct increase (decrease) in accumulated other comprehensive income in shareholders’ equity, net of deferred tax and, accordingly, have no effect on net income.

Income Taxes


Deferred income taxes represent the expected future tax consequences when the reported amounts of assets and liabilities are recovered or paid. They arise from differences between the financial reporting and tax basis of assets and liabilities and are adjusted for changes in tax laws and tax rates as those changes are enacted. The provision for income taxes represents the total amount of income taxes due related to the current year, plus the change in deferred income taxes during the year. A valuation allowance is recognized if, based on management’s assessment of the relevant facts, it is more likely than not that some portion of a deferred tax asset will not be realized.
Earnings Per Common Share


Basic earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period. Diluted earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period, plus options outstanding, if applicable, using the treasury stock method and the assumed conversion of the Series D preferred stock, if dilutive. Unless otherwise indicated, earnings per common share amounts are presented on a diluted basis.

Cash and Cash Equivalents


Cash and cash equivalents consist of cash on hand and investments in short-term, highly liquid securities with original maturities of three months or less from date of purchase.

Reinsurance


The Company’s insurance subsidiaries from time to time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect against catastrophic losses. In a reinsurance transaction, an insurance company transfers, or “cedes,” a portion or all of its exposure on insurance policies to a reinsurer. The reinsurer assumes the exposure in return for a portion of the premiums. The ceding of insurance does not legally discharge the insurer from primary liability for the full amount of the policies written by it, and the ceding company will incur a loss if the reinsurer fails to meet its obligations under the reinsurance agreement.



Amounts currently recoverable under reinsurance agreements are included in reinsurance receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.


Share-Based Transactions


For employee and director share-based compensation awards, the Company determines a grant date fair value based on the price of our publicly-traded common stock and recognize the related compensation expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation awards, the Company recognizes the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

Treasury Stock


Treasury stock is reflected as a reduction of shareholders’ equity at cost. The Company uses the first-in-first-out (“FIFO”) purchase cost to determine the cost of treasury stock that is reissued. The Company includes any gains and losses in additional paid-in capital when treasury stock is reissued.

Recently Issued Accounting Standards


Adoption of New Accounting Standards


Reference Rate Reform. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This guidance provides optional expedients and exceptions for applying GAAP to investments, derivatives, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. Along with the optional expedients, the amendments include a general principle that permits an entity to consider contract modifications due to reference reform to be an event that does not require contract re-measurement at the modification date or reassessment of a previous accounting determination. Additionally, a company may make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform and that were classified as held to maturity before January 1, 2020. The Company adopted the guidance as of June 30, 2023. The adoption of the guidance had no significant impact on the Company’s financial condition and results of operations.


Financial Instruments – Credit Losses. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). The updated guidance applies a new credit loss model (current expected credit losses or CECL) for determining credit-related impairments for financial instruments measured at amortized cost (including reinsurance recoverables, premium and other receivables) and requires an entity to estimate the credit losses expected over the life of an exposure or pool of exposures. The estimate of expected credit losses should consider historical information, current information, as well as reasonable and supportable forecasts, including estimates of prepayments. The expected credit losses, and subsequent adjustments to such losses, are recorded through an allowance account that is deducted from the amortized cost basis of the financial asset, with the net carrying value of the financial asset presented on the consolidated balance sheet at the amount expected to be collected.


The updated guidance also amends the previous other-than-temporary impairment model for available-for-sale debt securities by requiring the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. In addition, the length of time a security has been in an unrealized loss position will no longer impact the determination of whether a credit loss exists.


The Company adopted the updated guidance as of January 1, 2023. The updated guidance was applied by a cumulative effect adjustment to the opening balance of retained earnings as of January 1, 2023, the beginning of the period of adoption. The adoption of this guidance resulted in the recognition of an after-tax cumulative effect adjustment of $0.1 million to reflect the impact of recognizing expected credit losses, as compared to incurred credit losses recognized under the previous guidance. This adjustment is primarily associated with reinsurance recoverables, premium and other receivables. The cumulative effect adjustment decreased retained earnings as of January 1, 2023 and increased the allowance for estimated uncollectible reinsurance.



Impact of Adoption on Condensed Consolidated Balance Sheet



Reinsurance Recoverables



The following table presents the balances of reinsurance recoverables, net of the allowance for estimated uncollectible reinsurance, at January 1, 2023 and December 31, 2023, and the changes in the allowance for estimated uncollectible reinsurance for the year ended December 31, 2023.


   
Year ended December 31, 2023
 
(in thousands)
 
Reinsurance Recoverables,
Net of Allowance for Estimated
Uncollectible Reinsurance
   
Allowance for Estimated
Uncollectible Reinsurance
 
Balance, beginning of period
 
$
25,913
   
$
 
Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
   
     
75
 
Current period change for estimated uncollectible reinsurance
           
(14
)
Write-offs of uncollectible reinsurance recoverables
           
 
Balance, end of period
 
$
21,103
   
$
61
 


Insurance Premium and Other Receivables



The following table presents the balances of insurance premiums and other, net of the allowance for expected credit losses, at January 1, 2023 and December 31, 2023, and the changes in the allowance for doubtful accounts/expected credit losses for the year ended December 31, 2023.


   
Year ended December 31, 2023
 
(in thousands)
 
Insurance Premiums and
Other, Net of Expected Credit
Losses
   
Allowance for Doubtful
Accounts/Expected Credit
Losses
 
Balance, beginning of period
 
$
15,386
   
$
177
 
Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
   
     
 
Current period change for expected credit losses
           
40
 
Write-offs of uncollectible insurance premiums and other receivables
             
Balance, end of period
 
$
23,690
   
$
217
 



Future Adoption of New Accounting Standards



Accounting for Long-Duration Contracts. In August 2018, the FASB issued ASU No. 2018-12, Financial Services —Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”). This guidance (1) improves the timeliness of recognizing changes in the liability for future policy benefits and modifies the rate used to discount future cash flows, (2) simplifies and improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts, (3) simplifies the amortization of deferred acquisition costs, and (4) improves the effectiveness of the required disclosures. ASU 2018-12 is effective for annual reporting periods beginning after December 15, 2024 and interim periods beginning after December 15, 2025, although earlier adoption is permitted.  The Company is currently evaluating the new guidance, but has not yet determined the method. The Company will adopt on January 1, 2025.



Segment Reporting. In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting- An Amendment for Improvements to Reportable Segment Disclosures (Topic 280). The amendments in ASU 2023-07 improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. The amendment; introduces a new requirement to disclose significant segment expenses regularly provided to the chief operating decision maker (CODM); extends certain annual disclosures to interim periods; clarifies single reportable segment entities must apply ASC 280 in its entirety, permits more than one measure of segment profit or loss to be reported under certain conditions, and requires disclosure of the title and position of the CODM. The amendments in this update do not change or remove existing disclosure requirements. The Update is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, although early adoption is permitted. The Company is evaluating the new guidance and any effect it will have on the Company’s financials.



Income Taxes. In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The amendment requires that all entities disclose on an annual basis the following information about income taxes paid; the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received). All entities also are required to disclose; income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign; and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU, which also includes certain other amendments to improve the effectiveness of income tax disclosures, is effective for public business entities for annual periods beginning after Dec. 15, 2024. The Company is evaluating the new guidance and any effect it will have on the Company’s financials.

Use of Estimates in the Preparation of Financial Statements


The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Significant estimates and assumptions are used in developing and evaluating deferred income taxes, deferred acquisition costs, insurance reserves, investments, and receivables, among others, and actual results could differ materially from management’s estimates.

Note 2.
Investments


The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses, allowance for credit losses and cost or amortized cost of the Company’s investments in fixed maturities and equity securities, aggregated by type and industry, as of December 31, 2023 and December 31, 2022.


Fixed maturities were comprised of the following:

    2023
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Allowance
for
Credit
Losses
   
Amortized
Cost
 
Fixed maturities:
                             
Bonds:
                             
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
50,059
   
$
63
   
$
4,944
    $    
$
54,940
 
Obligations of states and political subdivisions
   
8,106
     
15
     
1,424
           
9,515
 
Corporate securities:
                                       
Utilities and telecom
   
21,309
     
143
     
2,582
           
23,748
 
Financial services
   
59,584
     
560
     
4,931
           
63,955
 
Other business – diversified
   
34,386
     
403
     
2,940
           
36,923
 
Other consumer – diversified
   
44,570
     
87
     
4,870
           
49,353
 
Total corporate securities
   
159,849
     
1,193
     
15,323
           
173,979
 
Redeemable preferred stocks:
                                       
Other consumer – diversified
   
205
     
13
     
           
192
 
Total redeemable preferred stocks
   
205
     
13
     
           
192
 
Total fixed maturities
 
$
218,219
   
$
1,284
   
$
21,691
    $
   
$
238,626
 

   
2022
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Amortized
Cost
 
Fixed maturities:
                       
Bonds:
                       
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
44,412
   
$
5
   
$
5,926
   
$
50,333
 
Obligations of states and political subdivisions
   
9,187
     
4
     
1,702
     
10,885
 
Corporate securities:
                               
Utilities and telecom
   
22,090
     
120
     
3,299
     
25,269
 
Financial services
   
59,054
     
397
     
7,085
     
65,742
 
Other business – diversified
   
31,058
     
161
     
4,689
     
35,586
 
Other consumer – diversified
   
42,705
     
35
     
6,089
     
48,759
 
Total corporate securities
   
154,907
     
713
     
21,162
     
175,356
 
Redeemable preferred stocks:
                               
Other consumer – diversified
   
223
     
31
     
     
192
 
Total redeemable preferred stocks
   
223
     
31
     
     
192
 
Total fixed maturities
 
$
208,729
   
$
753
   
$
28,790
   
$
236,766
 


Bonds having an amortized cost of $14,647 and $12,333 and included in the tables above were on deposit with insurance regulatory authorities at December 31, 2023 and 2022, respectively, in accordance with statutory requirements. Additionally, bonds having an amortized cost of $9,584 and $7,221 and included in the tables above were pledged as collateral to FHLB at December 31, 2023 and 2022, respectively.

   
2023
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Cost
 
Equity securities:
                       
Common and non-redeemable preferred stocks:
                       
Financial services
   
924
     
621
     
     
303
 
Communications
   
8,489
     
3,856
     
     
4,633
 
Total equity securities
 
$
9,413
   
$
4,477
   
$
   
$
4,936
 

   
2022
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Cost
 
Equity securities:
                       
Common and non-redeemable preferred stocks:
                       
Financial services
   
790
     
516
     
     
274
 
Communications
   
10,772
     
6,139
     
     
4,633
 
Total equity securities
 
$
11,562
   
$
6,655
   
$
   
$
4,907
 

The carrying value and amortized cost of the Company’s investments in fixed maturities at December 31, 2023 and 2022 by contractual maturity were as follows. Actual maturities may differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.

   
2023
   
2022
 
   
Carrying
Value
   
Amortized
Cost
   
Carrying
Value
   
Amortized
Cost
 
Due in one year or less
 
$
1,715
   
$
1,750
   
$
3,776
   
$
3,797
 
Due after one year through five years
   
60,423
     
62,423
     
40,150
     
42,174
 
Due after five years through ten years
   
33,596
     
36,752
     
44,044
     
49,711
 
Due after ten years
   
86,857
     
97,984
     
87,719
     
103,095
 
Asset backed securities
   
35,628
     
39,717
     
33,040
     
37,989
 
Totals
 
$
218,219
   
$
238,626
   
$
208,729
   
$
236,766
 

The following tables present the Company’s unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of December 31, 2023 and 2022.

   
2023
 
   
Less than 12 months
   
12 months or longer
   
Total
 
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
 
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
5,194
   
$
37
   
$
39,476
   
$
4,907
   
$
44,670
   
$
4,944
 
Obligations of states and political subdivisions
    1,145       3       5,936       1,421       7,081       1,424  
Corporate securities
   
539
     
13
     
138,283
     
15,310
     
138,822
     
15,323
 
Total temporarily impaired securities
 
$
6,878
   
$
53
   
$
183,695
   
$
21,638
   
$
190,573
   
$
21,691
 

   
2022
 
   
Less than 12 months
   
12 months or longer
   
Total
 
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
 
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
23,763
   
$
2,410
   
$
19,259
   
$
3,516
   
$
43,022
   
$
5,926
 
Obligations of states and political subdivisions
    8,183       1,702                   8,183       1,702  
Corporate securities
   
127,928
     
16,214
     
14,514
     
4,948
     
142,442
     
21,162
 
Total temporarily impaired securities
 
$
159,874
   
$
20,326
   
$
33,773
   
$
8,464
   
$
193,647
   
$
28,790
 


Analysis of Securities in Unrealized Loss Positions



As of December 31, 2023 and 2022, there were 311 and 237 securities, respectively, in an unrealized loss position which primarily included certain of the Company’s investments in fixed maturities within the utilities and telecom, financial services, other diversified business and other diversified consumer sectors. The unrealized losses on the Company’s fixed maturity securities investments have been primarily related to general market changes in interest rates and/or the levels of credit spreads rather than specific concerns with the issuer’s ability to pay interest and repay principal.


For any of its fixed maturity securities with significant declines in fair value, the Company performs detailed analyses to identify whether the drivers of the declines are due to general market drivers, such as the recent increases in interest rates, or due to credit-related factors. Identifying the drivers of the declines in fair value helps to align and allocate the Company‘s resources to securities with real credit-related concerns that could impact the ultimate collection of principal and interest. For any significant declines in fair value determined to be non-interest rate or market related, the Company performs a more focused review of the related issuers’ specific credit profile.


For corporate issuers, the Company evaluates their assets, business profile including industry dynamics and competitive positioning, financial statements and other available financial data. For non-corporate issuers, the Company analyzes all reasonably available sources of credit support, including issuer-specific factors. The Company utilizes information available in the public domain and, for certain private placement issuers, from consultations with the issuers directly. The Company also considers ratings from Nationally Recognized Statistical Rating Organizations (NRSROs), as well as the specific characteristics of the security it owns including seniority in the issuer’s capital structure, covenant protections, or other relevant features. From these reviews, the Company evaluates the issuers’ continued ability to service the Company’s investment through payment of interest and principal.



Assuming no credit-related factors develop, unrealized gains and losses on fixed maturity securities are expected to diminish as investments near maturity. Based on its credit analysis, the Company believes that the issuers of its fixed maturity investments in the sectors shown in the table above have the ability to service their obligations to the Company. In addition, the Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.

However, from time to time the Company identifies certain available-for-sale fixed maturity securities where the amortized cost basis exceeds the present value of the cash flows expected to be collected due to credit related factors and as a result, a credit allowance will be estimated.  The Company had no ACL on its available-for-sale fixed maturities as of December 31, 2023. The Company did not record any other than temporary impairments as of December 31, 2022.


Investment income was earned from the following sources:

   
2023
   
2022
 
Fixed maturities
 
$
9,333
   
$
9,141
 
Equity securities
   
332
     
327
 
Other
   
646
   
729
     
10,311
     
10,197
 
Investment expenses
   
253
     
265
 
Net investment income
 
$
10,058
   
$
9,932
 


A summary of realized investment gains (losses) follows:

    2023  
 
Fixed
Maturities
   
Equity
Securities
   
Other
Invested Assets
    Total  
Gains
 
$
70
   
$
   
$
   
$
70
 
Losses
   
   
     
   
Realized investment gains, net
 
$
70
   
$
   
$
 
$
70
 

    2022  
   
Fixed
Maturities
   
Equity
Securities
   
Other
Invested Assets
    Total  
Gains
 
$
101
   
$
   
$
1
   
$
102
 
Losses
   
(52
)
   
     
(20
)
   
(72
)
Realized investment gains (losses), net
 
$
49
   
$
   
$
(19
)
 
$
30
 


Proceeds from the sales of available-for-sale fixed maturities were as follows:

   
2023
   
2022
 
Sales proceeds
 
$
5,035
   
$
3,649
 
Gross gains
   
70
     
101
 
Gross losses
   
   


Proceeds from the sales of equity securities were as follows:

   
2023
   
2022
 
Sales proceeds
 
$
2
   
$
1
 
Gross gains
   
     
 
Gross losses
   
     


Proceeds from the sales of other invested assets were as follows:

   
2023
   
2022
 
Sales proceeds
 
$
   
$
161
 
Gross gains
   
     
1
 
Gross losses
   
     
(20
)


Sales of available-for-sale securities in 2023 and 2022 were primarily a result of improving the overall risk versus return profile of the portfolio. In addition, the Company sold its interest in a certain limited liability company held as other invested assets to a third-party in 2022.

The following table presents the portion of unrealized gains (losses) related to equity securities still held for the years ended December 31, 2023 and 2022.

   
2023
   
2022
 
Net realized and unrealized gains (losses) recognized during the period on equity securities
 
$
(2,177
)
 
$
(7,562
)
Less: Net realized gains recognized during the period on equity securities sold during the period
   
     
 
Unrealized gains (losses) on equity securities, net
 
$
(2,177
)
 
$
(7,562
)


The Company’s bond portfolio included 99% investment grade securities, as defined by the NAIC, at December 31, 2023 and 2022.

Variable Interest Entities


The Company holds passive interests in a number of entities that are considered to be variable interest entities (“VIEs”) under GAAP guidance. The Company’s VIE interests principally consist of interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns. The Company’s VIE interests, carried as a part of other invested assets, totaled $6,381 and $5,386 at December 31, 2023 and 2022, respectively. The Company’s VIE interests, carried as a part of investment in unconsolidated trusts, totaled $1,238 at December 31, 2023 and 2022.



The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not consolidated these VIEs. The Company’s involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other financial support to or on behalf of the VIE. The Company’s maximum loss exposure relative to these investments was limited to the carrying value of the Company’s investment in the VIEs, which amount to $7,619 and $6,624, at December 31, 2023 and 2022, respectively. As of December 31, 2023 and 2022, the Company had outstanding commitments totaling $4,518 and $5,872, respectively, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new investments and partnership expenses. The reduction in the Company’s outstanding commitments was a result of an additional investment of $1,354 in the partnership.

Note 3.
Disclosures About Fair Value of Financial Instruments


The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates. However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.


The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.


Level 1
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria include cash equivalents and exchange traded common stocks.


Level 2
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers. Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.


Level 3
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of one equity security.  As of December 31, 2023 and December 31, 2022, the value of the equity security valued using Level 3 criteria was $185 and $156, respectively.   The equity security is not traded and is valued at cost. The use of different criteria or assumptions regarding data may have yielded materially different valuations.
Recurring Fair Value Measurements

Cash Equivalents. The carrying amount approximates fair value due to the short-term nature of the instruments.

Fixed Maturities and Common and Non-Redeemable Preferred Stocks. The carrying amount is determined from publicly quoted market prices. Certain fixed maturities do not have publicly quoted values and consist solely of issuances of pooled debt obligations of multiple, smaller financial services companies. They are not actively traded and valuation techniques used to measure fair value are based on future estimated cash flows discounted at reasonable estimated rates of interest. Other qualitative and quantitative information is also considered, as applicable.

Nonrecurring Fair Value Measurements

Non-publicly Traded Invested Assets. The fair value of investments in certain limited partnerships which are included in other invested assets on the consolidated balance sheet were determined by officers of those limited partnerships.

Policy Loans. Policy loans, which are categorized as Level 3 fair value measurements, are carried at the unpaid principal balances.

Junior Subordinated Debentures. The fair value is estimated based on observable interest rates and yields for debt instruments having similar characteristics.


As of December 31, 2023, financial instruments carried at fair value were measured on a recurring basis as summarized below:


Assets:
 
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
Fixed maturities
 
$
   
$
218,219
   
$
   
$
218,219
 
Equity securities
   
9,228
     
     
185
     
9,413
 
Cash equivalents
   
14,834
     
     
     
14,834
 
Total
 
$
24,062
   
$
218,219
   
$
185
   
$
242,466
 


As of December 31, 2022, financial instruments carried at fair value were measured on a recurring basis as summarized below:

Assets:
 
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
Fixed maturities
 
$
   
$
208,729
   
$
   
$
208,729
 
Equity securities
   
11,406
     
     
156
     
11,562
 
Cash equivalents
   
18,861
     
     
     
18,861
 
Total
 
$
30,267
   
$
208,729
   
$
156
   
$
239,152
 


The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company’s financial instruments as of December 31, 2023 and 2022.

   
Level in
   
2023
   
2022
 
   
Fair Value
Hierarchy(1)
   
Carrying
Amount
   
Estimated
Fair Value
   
Carrying
Amount
   
Estimated
Fair Value
 
Assets:
                             
Cash and cash equivalents
 
Level 1
   
$
28,301
   
$
28,301
   
$
28,863
   
$
28,863
 
Fixed maturities
 
Level 2

   
218,219
     
218,219
     
208,729
     
208,729
 
Equity securities
 
(1) 

   
9,413
     
9,413
     
11,562
     
11,562
 
Policy loans
 
Level 3
     
1,778
     
1,778
     
1,759
     
1,759
 
                                         
Liabilities:
                                       
Junior subordinated debentures, net
 
Level 2
     
33,738
     
33,670
     
33,738
     
33,810
 
Revolving credit facility
 
Level 2
      3,019       3,019       2,009       2,009  

(1)
See the aforementioned information for a description of the fair value hierarchy as well as a disclosure of levels for classes of these financial assets.


Note 4.
Deferred Policy Acquisition Costs


The following table presents a rollforward of deferred policy acquisition costs by segment for the years ended December 31.

    2023     2022
 
   
American
Southern
   
Bankers
Fidelity
   
American
Southern
   
Bankers
Fidelity
 
Deferred policy acquisition costs:
                       
Balance, beginning of year
 
$
2,401
   
$
39,880
   
$
2,390
   
$
36,308
 
Capitalization
   
8,689
     
9,320
     
10,161
     
12,867
 
Amortization
   
(8,390
)
   
(8,050
)
   
(10,150
)
   
(9,295
)
Balance, end of year
 
$
2,700
   
$
41,150
   
$
2,401
   
$
39,880
 

Note 5. Internal-Use Software


On March 3, 2021, the Company entered into a hosting arrangement through a service contract with a third party software solutions vendor to provide a suite of policy, billing, claim, and customer management services. The software is managed, hosted, supported, and delivered as a cloud-based software service product offering (software-as-a-service). The initial term of the arrangement is five years from the effective date with a renewal term of an additional five years.



Service fees related to the hosting arrangement are recorded as an expense in the Company’s condensed consolidated statement of operations as incurred.  Implementation expenses incurred related to third party professional and consulting services have been capitalized. The Company will begin amortizing, on a straight-line basis over the expected ten year term of the hosting arrangement, when the software is substantially ready for its intended use. The Company incurred and capitalized implementation costs of $1,545 and $2,522 during the years ended December 31, 2023 and 2022, respectively. The Company has capitalized $4,567 and $3,022 in implementation costs in other assets in its condensed consolidated balance sheet as of December 31, 2023 and 2022, respectively.  The Company expects the software will be substantially ready for its intended use during 2024. Accordingly, the Company has not recorded any amortization expense related to software implementation costs for years ended December 31, 2023 and 2022.

Note 6.
Insurance Reserves and Policyholder Funds


The following table presents the Company’s reserves for life, accident and health, and property and casualty losses, claims and loss adjustment expenses at December 31, 2023 and 2022.

               
Amount of
Insurance In Force, Net
 
   
2023
   
2022
   
2023
   
2022
 
Future policy benefits
                       
Life insurance policies:
                       
Ordinary life and annuities
 
$
50,040
   
$
50,660
   
$
172,907
   
$
186,863
 
Group life
   
11,917
     
2,533
     
633,017
     
474,150
 
     
61,957
     
53,193
   
$
805,924
   
$
661,013
 
Accident and health insurance policies
   
30,538
     
32,371
                 
     
92,495
     
85,564
                 
Unearned premiums
   
31,317
     
28,348
                 
Losses, claims and loss adjustment expenses
   
87,478
     
87,484
                 
Other policy liabilities
   
1,132
     
1,255
                 
Total insurance reserves and policyholder funds
 
$
212,422
   
$
202,651
                 


Annualized premiums for accident and health insurance policies were $84,127 and $89,471 at December 31, 2023 and 2022, respectively.
Future Policy Benefits


Liabilities for future benefits on life insurance policies and accident and health insurance policies are based on assumed investment yields, mortality rates, disablement rates, benefit utilization rates, and lapse rates after giving effect to possible risks of unexpected adverse claim experience. The mortality, disablement rates, benefit utilization rates, and lapse assumptions are based upon the Company’s experience and incorporate a margin for adverse experience development.  These assumptions are modified as necessary to reflect anticipated trends and are generally established at contract inception.  The interest rates assumed, which reflect future investment yields at the time policies are issued, are generally: (i) 2.5% to 5.5% for issues prior to 1977, (ii) 5.5% to 7.0% for 1977 through 1979 issues, (iii) 9.0% for 1980 through 1987 issues, (iv) 5.0% to 7.0% for 1988 through 2009 issues, and (v) 3.0% to 4.0% for 2010 through 2023 issues.

Loss and Claim Reserves


Loss and claim reserves represent estimates of projected ultimate losses and are based upon: (a) management’s estimate of ultimate liability and claims adjusters’ evaluations for unpaid claims reported prior to the close of the accounting period, (b) estimates of incurred but not reported (“IBNR”) claims based on past experience, and (c) estimates of loss adjustment expenses. The estimated liability is periodically reviewed by management and updated, with changes to the estimated liability recorded in the statement of operations in the year in which such changes are known.


Activity in the liability for unpaid loss and claim reserves is summarized as follows:

   
2023
   
2022
 
Balance at January 1
 
$
87,484
   
$
85,620
 
Less: Reinsurance recoverable on unpaid losses
   
(17,647
)
   
(17,690
)
Net balance at January 1
   
69,837
     
67,930
 
                 
Incurred related to:
               
Current year
   
113,246
     
125,754
 
Prior years
   
1,418
(1)
   
(4,228
)(2)
Total incurred
   
114,664
     
121,526
 
                 
Paid related to:
               
Current year
   
67,484
     
82,002
 
Prior years
   
44,217
     
37,617
 
Total paid
   
111,701
     
119,619
 
Net balance at December 31
   
72,800
     
69,837
 
Plus: Reinsurance recoverable on unpaid losses
   
14,678
     
17,647
 
Balance at December 31
 
$
87,478
   
$
87,484
 


(1)
Prior years’ development was primarily the result of unfavorable development in the automobile liability line of business in the property and casualty operations due to inflationary factors.

(2)
Prior years’ development was primarily the result of favorable development in the Medicare supplement line of business in the life and health operations, as well as favorable development in the surety line of business in the property and casualty operations.



Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:

   
2023
   
2022
 
Total incurred losses
 
$
114,664
   
$
121,526
 
Cash surrender value and matured endowments
   
1,323
     
1,598
 
Benefit reserve changes
   
6,513
     
332
Total insurance benefits and losses incurred
 
$
122,500
   
$
123,456
 

Liability for Unpaid Losses, Claims and Loss Adjustment Expenses


The following is information, by significant product lines, about incurred and paid claims development as of December 31, 2023, net of reinsurance, as well as the cumulative number of reported claims and the total of IBNR reserves plus expected development on reported claims included within the net incurred claims amounts. The information presented for the years ended December 31, 2015 and prior is presented as supplementary information and is unaudited.
Medicare Supplement

   
For the Years Ended December 31,
   
As of December 31,
2023
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported Claims
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
57,179
   
$
56,938
   
$
56,981
   
$
56,981
   
$
56,976
   
$
56,977
   
$
56,976
   
$
56,976
   
$
56,976
   
$
56,976
   
$
     
940
 
2015
           
55,482
     
54,939
     
54,993
     
54,990
     
54,984
     
54,985
     
54,985
     
54,985
     
54,985
     
     
898
 
2016
                   
58,849
     
59,851
     
63,226
     
63,225
     
63,221
     
63,221
     
63,221
     
63,221
     
     
1,037
 
2017
                           
67,960
     
69,655
     
69,643
     
69,635
     
69,633
     
69,633
     
69,632
     
     
1,512
 
2018
                                   
79,140
     
80,404
     
80,361
     
80,357
     
80,351
     
80,348
     
     
2,052
 
2019
                                           
88,765
     
87,028
     
86,988
     
86,986
     
86,980
     
     
2,246
 
2020
                                                   
75,857
     
75,715
     
75,730
     
75,730
     
14
     
1,853
 
2021
                                                            65,267
     
61,579
     
61,785
     
52
     
1,771
 
2022
                                                                   
58,777
     
56,047
     
239
     
2,103
 
2023
                                                                           
48,367
     
11,979
     
1,864
 
                                                                           
$
654,071
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
48,024
   
$
56,938
   
$
56,981
   
$
56,981
   
$
56,976
   
$
56,977
   
$
56,976
   
$
56,976
   
$
56,976
   
$
56,976
 
2015
           
45,430
     
54,876
     
54,993
     
54,990
     
54,984
     
54,985
     
54,985
     
54,985
     
54,985
 
2016
                   
49,165
     
59,747
     
63,226
     
63,225
     
63,221
     
63,221
     
63,221
     
63,221
 
2017
                           
57,696
     
69,517
     
69,643
     
69,635
     
69,633
     
69,633
     
69,633
 
2018
                                   
66,565
     
80,222
     
80,361
     
80,355
     
80,351
     
80,348
 
2019
                                           
72,333
     
86,856
     
86,978
     
86,985
     
86,980
 
2020
                                                   
63,129
     
75,527
     
75,710
     
75,715
 
2021
                                                           
50,197
     
61,350
     
61,733
 
2022
                                                                   
46,111
     
55,808
 
2023
                                                                           
36,388
 
                                                                           
$
641,787
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
12,284
 


The cumulative number of reported claims for the Medicare Supplement line of business is the number of distinct claims incurred and submitted to the Centers for Medicare and Medicaid Services (or its designee) for payment in the given year. Multiple payments on the same claim are not counted in the claim frequency data. Estimated ultimate claims incurred, using claims data reported during each month of any given year, are calculated using the chain ladder method modified to reflect seasonality by trend-adjusting expected claims for the most recent four-month period prior to the statement date. Additional adjustments to the estimated ultimate claims incurred are then applied to account for seasonal changes in claim experience and changes in the rate of claim processing. The IBNR is calculated as the estimated ultimate claims less the total of paid claims through the valuation date and claims in the course of settlement as of the valuation date. Thirty-six months of loss data are used to develop the estimated ultimate incurred claims. For other accident and health products that have very small claim volumes, similar approaches are used and modified to reflect the unique aspects of the products.

Automobile Liability

   
For the Years Ended December 31,
   
As of December 31,
2023
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported
Claims
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
20,812
   
$
21,881
   
$
22,041
   
$
22,353
   
$
21,682
   
$
22,080
   
$
22,100
   
$
22,125
   
$
22,165
   
$
22,095
   
$
     
3,560
 
2015
           
18,521
     
19,857
     
20,017
     
20,007
     
20,086
     
20,680
     
20,849
     
20,955
     
21,021
     
     
3,537
 
2016
                   
20,549
     
21,275
     
21,846
     
22,388
     
22,245
     
22,310
     
22,448
     
22,448
     
     
3,862
 
2017
                           
22,179
     
24,212
     
23,766
     
25,180
     
26,009
     
26,153
     
26,231
     
1
     
3,813
 
2018
                                   
24,284
     
25,682
     
27,338
     
30,013
     
30,464
     
31,135
     
323
     
3,651
 
2019
                                           
25,241
     
24,045
     
25,724
     
28,042
     
28,513
     
397
     
3,606
 
2020
                                                   
22,416
     
16,442
     
20,137
     
21,164
     
1,010
     
2,517
 
2021
                                                           
25,887
     
21,172
     
24,957
     
1,899
     
2,774
 
2022
                                                                   
28,860
     
27,293
     
3,093
     
2,845
 
2023
                                                                           
33,266
     
16,714
     
2,558
 
                                                                           
$
258,123
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
6,822
   
$
13,807
   
$
17,554
   
$
20,177
   
$
20,878
   
$
21,735
   
$
21,813
   
$
21,786
   
$
21,958
   
$
22,095
 
2015
           
6,226
     
11,878
     
14,938
     
17,612
     
19,557
     
20,234
     
20,726
     
20,904
     
21,021
 
2016
                   
6,796
     
13,141
     
16,397
     
19,613
     
21,408
     
21,809
     
22,448
     
22,448
 
2017
                           
7,401
     
16,317
     
20,221
     
22,778
     
25,023
     
25,712
     
26,222
 
2018
                                   
6,989
     
15,647
     
21,121
     
24,662
     
27,671
     
29,201
 
2019
                                           
7,305
     
14,694
     
19,384
     
22,868
     
26,126
 
2020
                                                   
5,172
     
9,941
     
14,693
     
18,133
 
2021
                                                           
6,242
     
13,918
     
19,230
 
2022
                                                                   
7,023
     
18,010
 
2023
                                                                           
9,068
 
                                                                           
$
211,554
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
46,569
 

Automobile Physical Damage

   
For the Years Ended December 31,
   
As of December 31, 2023
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses,
Net of Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported
Claims
 
Accident Year
 
2019
   
2020
   
2021
   
2022
   
2023
 
2019
 
$
8,526
   
$
8,026
   
$
7,914
   
$
7,881
   
$
7,873
   
$
1
     
1,495
 
2020
           
10,288
     
10,080
     
10,047
     
10,024
     
3
     
1,642
 
2021
                   
14,296
     
13,385
     
13,305
     
4
     
1,900
 
2022
                           
10,962
     
10,648
     
33
     
1,756
 
2023
                                   
6,460
     
96
     
1,401
 
                                   
$
48,310
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment
Expenses, Net of Reinsurance
 
Accident Year
 
2019
   
2020
   
2021
   
2022
   
2023
 
2019
 
$
6,360
   
$
8,005
   
$
7,906
   
$
7,867
   
$
7,866
 
2020
           
8,347
     
9,952
     
10,008
     
9,992
 
2021
                   
11,993
     
13,277
     
13,257
 
2022
                           
8,475
     
10,368
 
2023
                                   
5,397
 
                                   
$
46,880
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
1,430
 

General Liability

   
For the Years Ended December 31,
   
As of December 31,
2023
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported
Claims
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
3,744
   
$
501
   
$
557
   
$
476
   
$
406
   
$
497
   
$
523
   
$
519
   
$
511
   
$
514
   
$
2
     
207
 
2015
           
4,421
     
1,037
     
1,227
     
1,044
     
867
     
855
     
855
     
870
     
870
     
     
149
 
2016
                   
3,119
     
1,148
     
736
     
608
     
621
     
619
     
620
     
620
     
     
94
 
2017
                           
1,490
     
488
     
513
     
738
     
738
     
839
     
777
     
     
84
 
2018
                                   
1,656
     
333
     
198
     
128
     
183
     
183
     
     
76
 
2019
                                           
1,916
     
707
     
455
     
515
     
909
     
117
     
95
 
2020
                                                   
2,223
     
670
     
657
     
363
     
(66
)
   
89
 
2021
                                                           
2,567
     
1,329
     
1,328
     
215
     
102
 
2022
                                                                   
2,770
     
2,380
     
634
     
122
 
2023
                                                                           
2,887
     
1,906
     
87
 
                                                                           
$
10,831
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
171
   
$
299
   
$
331
   
$
369
   
$
373
   
$
493
   
$
498
   
$
502
   
$
502
   
$
505
 
2015
           
98
     
259
     
464
     
664
     
863
     
855
     
855
     
854
     
854
 
2016
                   
116
     
203
     
568
     
608
     
617
     
619
     
620
     
620
 
2017
                           
75
     
136
     
365
     
556
     
696
     
741
     
777
 
2018
                                   
65
     
90
     
115
     
128
     
183
     
183
 
2019
                                           
41
     
209
     
242
     
354
     
404
 
2020
                                                   
208
     
385
     
462
     
539
 
2021
                                                           
364
     
646
     
813
 
2022
                                                                   
402
     
1,169
 
2023
                                                                           
125
 
                                                                           
$
5,989
 
All outstanding liabilities before 2014, net of reinsurance
     
341
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
5,183
 

Surety

   
For the Years Ended December 31,
   
As of December 31,
2023
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported
Claims
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
3,214
   
$
3,130
   
$
2,990
   
$
2,760
   
$
2,685
   
$
2,617
   
$
2,818
   
$
2,782
   
$
2,852
   
$
2,592
   
$
4
     
54
 
2015
           
1,902
     
1,630
     
1,400
     
1,359
     
1,406
     
1,310
     
1,307
     
1,280
     
1,279
     
     
50
 
2016
                    3,314
     
1,812
     
1,865
     
1,876
     
1,865
     
1,678
     
1,670
     
1,666
     
     
47
 
2017
                           
4,677
     
3,671
     
3,799
     
3,629
     
3,514
     
3,440
     
3,448
     
8
     
67
 
2018
                                   
3,528
     
1,938
     
1,381
     
956
     
767
     
750
     
     
64
 
2019
                                           
2,130
     
657
     
630
     
513
     
507
     
11
     
32
 
2020
                                                   
2,263
     
574
     
465
     
460
     
     
23
 
2021
                                                           
2,936
     
1,455
     
1,497
     
     
35
 
2022
                                                                   
3,202
     
2,339
     
72
     
50
 
2023
                                                                           
2,634
     
1,590
     
108
 
                                                                           
$
17,172
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
   
2021
   
2022
   
2023
 
2014
 
$
1,331
   
$
2,327
   
$
2,727
   
$
2,739
   
$
2,664
   
$
2,593
   
$
2,562
   
$
2,562
   
$
2,568
   
$
2,570
 
2015
           
641
     
856
     
1,127
     
1,125
     
1,128
     
1,271
     
1,273
     
1,279
     
1,279
 
2016
                   
1,054
     
1,732
     
1,772
     
1,873
     
1,862
     
1,677
     
1,670
     
1,666
 
2017
                           
1,971
     
3,255
     
3,523
     
3,545
     
3,442
     
3,402
     
3,400
 
2018
                                   
1,157
     
1,454
     
1,361
     
941
     
760
     
749
 
2019
                                           
259
     
395
     
568
     
446
     
444
 
2020
                                                   
97
     
460
     
464
     
459
 
2021
                                                           
156
     
803
     
1,496
 
2022
                                                                   
970
     
2,191
 
2023
                                                                           
98
 
                                                                           
$
14,352
 
All outstanding liabilities before 2014, net of reinsurance
     
33
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
2,853
 

For the property and casualty lines of business, the number of claims presented above equals the number of occurrences by type of claim reported to the Company. The number of claims reported during a given year corresponds to the number of claims records opened during the year. Frequency information is maintained on a cumulative basis by accident year by line of business. For automobile claims, a claim count is separately maintained for bodily injury, property damage and physical damage claims. The Company has consistently monitored claim frequency on this basis, and believes this provides more meaningful information than using claimant count which can change over the course of settling a claim.



In general, when a claim is reported, claims representatives establish a “case reserve” for the estimated amount of the ultimate payment based on the known information of the claim at that time. Claims managers review and monitor all property and casualty claims in excess of $25,000. As new information becomes available or payments are made on a claim, the case reserve is adjusted to reflect the revised estimate of the ultimate amount to be paid out. Estimates and assumptions pertaining to individual claims are based on complex and subjective judgments and subject to change at any time as new information becomes available.


In addition to case reserves, IBNR reserves are established to provide for claims which have not been reported to the Company as of the reporting date as well as potential adverse development on known case reserves. IBNR reserve estimates are derived through a number of analytical techniques. Actuarial data is analyzed by line of business, coverage and accident year. Qualitative factors are also considered in determining IBNR reserves and include such factors as judicial decisions, general economic trends such as inflation, changes in policy forms, and underwriting changes. Reserves are reviewed quarterly and any indicated adjustments are made.


Because of the inherent uncertainties in establishing both case and IBNR reserves, ultimate loss experience may prove better or worse than indicated by the combined claim reserves. Adjustments to claim reserves are reflected in the period recognized and could increase or decrease earnings for the period.


The following is supplementary information about average historical claims duration as of December 31, 2023.

   
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Unaudited)
 
Reserve Line
 
1st Year
   
2nd Year
   
3rd Year
   
4th Year
   
5th Year
   
6th Year
   
7th Year
   
8th Year
   
9th Year
   
10th Year
 
Medicare Supplement
   
81.9
%
   
17.1
%
   
0.2
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
Automobile Liability
   
26.9
%
   
29.8
%
   
17.3
%
   
12.6
%
   
8.3
%
   
3.3
%
   
1.9
%
   
0.2
%
   
0.7
%
   
0.6
%
Automobile Physical Damage
   
83.5
%
   
16.1
%
   
-0.3
%
   
-0.3
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
General Liability
   
21.9
%
   
22.2
%
   
21.2
%
   
14.6
%
   
13.1
%
   
5.7
%
   
1.4
%
   
0.2
%
   
0.0
%
   
0.6
%
Surety
   
50.4
%
   
41.5
%
   
14.5
%
   
-10.6
%
   
-5.1
%
   
-1.1
%
   
-0.4
%
   
0.1
%
   
0.1
%
   
0.1
%


The reconciliation of the net incurred and paid claims development tables to the liability for losses, claims and loss adjustment expenses is as follows:

   
December 31, 2023
 
Net outstanding liabilities
     
Medicare Supplement
 
$
12,284
 
Automobile Liability
   
46,569
 
Automobile Physical Damage
   
1,430
 
General Liability
   
5,183
 
Surety
   
2,853
 
Other short-duration insurance lines
   
2,391
 
Liabilities for unpaid losses, claims and loss adjustment expenses, net of reinsurance
   
70,710
 
         
Reinsurance recoverable on unpaid losses:
       
Medicare Supplement
   
8,263
 
Automobile Liability
   
3,870
 
Automobile Physical Damage
   
303
 
General Liability
   
2,242
 
Other short-duration insurance lines
     
Total reinsurance recoverable on unpaid losses
   
14,678
 
         
Unallocated claims adjustment expenses
   
2,090
 
         
Total gross liability for unpaid losses, claims and loss adjustment expenses
 
$
87,478
 
Note 7.
Reinsurance


In accordance with general practice in the insurance industry, portions of the life, property and casualty insurance written by the Company are reinsured; however, the Company remains liable with respect to reinsurance ceded should any reinsurer be unable or unwilling to meet its obligations. Approximately 99.7% of the Company’s reinsurance recoverables were due from a single reinsurer as of December 31, 2023. Reinsurance recoverables of $21,041 were due from General Re Corporation, rated “AA+” by Standard & Poor’s and “A++” (Superior) by A.M. Best. Allowances for uncollectible amounts are established against reinsurance recoverables, if appropriate.



Property and Casualty Operations


American Southern’s basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations. Limits per occurrence within the reinsurance treaties are as follows: Inland marine and commercial automobile physical damage - $225,000 excess of $125,000 retention; and automobile liability and general liability - excess coverage of $2.0 million less retentions that may vary from $150,000 to $500,000 depending on the account. American Southern maintains a property catastrophe treaty with a $5.5 million limit excess of $500,000 retention. American Southern also issues individual surety bonds with face amounts generally up to $1.5 million, and limited to $5.0 million in aggregate per account, that are not reinsured.


Life and Health Operations


Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention. Maximum retention by Bankers Fidelity on any one individual life insurance policyholder is $200,000. As of December 31, 2023, $8.3 million of the $814.2 million of life insurance in force at Bankers Fidelity was reinsured under a combination of coinsurance and yearly renewable term agreements. Certain prior year reinsurance agreements also remain in force although they no longer provide reinsurance for new business.


Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare Supplement business to General Re Life Corporation. Ceding thresholds are set annually. During 2023, the liability of the reinsurer was 50% of all new Medicare Supplement business issued by the Company on amounts up to a maximum retention of $15.0 million of annualized premium. Accordingly, $0.8 million of the Company’s $1.5 million of new annualized Medicare Supplement premium was ceded.



The effects of reinsurance on premiums written, premiums earned and insurance benefits and losses incurred were as follows:

   
For the Year Ended December 31, 2023
 
   
American
Southern
   
Bankers
Fidelity
   
Total
 
Direct premiums written
 
$
49,580
   
$
166,093
   
$
215,673
 
Assumed premiums written
   
27,987
     
29
     
28,016
 
Ceded premiums written
   
(5,902
)
   
(55,933
)
   
(61,835
)
Net premiums written
 
$
71,665
   
$
110,189
   
$
181,854
 
                         
Direct premiums earned
 
$
46,349
   
$
166,368
   
$
212,717
 
Assumed premiums earned
   
27,996
     
7
     
28,003
 
Ceded premiums earned
   
(5,902
)
   
(55,993
)
   
(61,895
)
Net premiums earned
 
$
68,443
   
$
110,382
   
$
178,825
 
                         
Provision for benefits and losses incurred
 
$
52,899
   
$
110,995
   
$
163,894
 
Reinsurance loss recoveries
   
(1,884
)
   
(39,510
)
   
(41,394
)
Insurance benefits and losses incurred
 
$
51,015
   
$
71,485
   
$
122,500
 
   
For the Year Ended December 31, 2022
 
   
American
Southern
   
Bankers
Fidelity
   
Total
 
Direct premiums written
 
$
52,404
   
$
176,119
   
$
228,523
 
Assumed premiums written
   
26,814
     
9
     
26,823
 
Ceded premiums written
   
(6,547
)
   
(61,701
)
   
(68,248
)
Net premiums written
 
$
72,671
   
$
114,427
   
$
187,098
 
                         
Direct premiums earned
 
$
51,844
   
$
176,995
   
$
228,839
 
Assumed premiums earned
   
24,978
     
8
     
24,986
 
Ceded premiums earned
   
(6,546
)
   
(61,839
)
   
(68,385
)
Net premiums earned
 
$
70,276
   
$
115,164
   
$
185,440
 
                         
Provision for benefits and losses incurred
 
$
49,568
   
$
124,478
   
$
174,046
 
Reinsurance loss recoveries
   
(2,393
)
   
(48,197
)
   
(50,590
)
Insurance benefits and losses incurred
 
$
47,175
   
$
76,281
   
$
123,456
 


Components of reinsurance receivables at December 31, 2023 and 2022 were as follows:

   
December 31, 2023
 
   
American
Southern
   
Bankers
Fidelity
   
Total
 
Recoverable on unpaid losses, net of allowance
 
$
6,415
   
$
8,263
   
$
14,678
 
Recoverable on unpaid benefits
   
     
5,470
     
5,470
 
Recoverable on paid losses
   
     
108
     
108
 
Ceded unearned premiums
   
     
621
     
621
 
Ceded advanced premiums
   
     
226
     
226
 
Total reinsurance receivables
 
$
6,415
   
$
14,688
   
$
21,103
 

    December 31, 2022  
   
American
Southern
   
Bankers
Fidelity
   
Total
 
Recoverable on unpaid losses
 
$
8,265
   
$
9,382
   
$
17,647
 
Recoverable on unpaid benefits
   
     
6,788
     
6,788
 
Recoverable on paid losses
   
     
618
     
618
 
Ceded unearned premiums
   
     
681
     
681
 
Ceded advanced premiums
   
     
179
     
179
 
Total reinsurance receivables
 
$
8,265
   
$
17,648
   
$
25,913
 

Note 8.
Income Taxes


Total income taxes were allocated as follows:

   
2023
   
2022
 
Total tax expense (benefit) on income
 
$
(394
)
 
$
571
 
                 
Tax expense (benefit) on components of shareholders’ equity:
               
Net unrealized income (losses) on investment securities
   
1,602
     
(10,589
)
Total tax expense (benefit)
 
$
1,208
   
$
(10,018
)

A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and the income tax expense (benefit) is as follows:

   
2023
   
2022
 
Federal income tax provision at the statutory rate
 
$
(119
)
 
$
440
 
Statutory rate
   
21
%
   
21
%
Dividends-received deduction
   
(24
)
   
(24
)
Meals and entertainment
   
15
     
61
 
Vested stock and club dues
   
16
     
14
 
Parking disallowance
   
17
     
17
 
Penalties and fines
          149  
Adjustment for prior years’ estimates to actual
   
(299
)
   
(86
)
Income tax expense (benefit)
 
$
(394
)
 
$
571
 
Effective tax rate
   
69.7
%
   
27.2
%


The primary difference between the effective tax rate and the federal statutory income tax rate for 2023 resulted from the adjustment for prior years’ estimates to actual of $299 in the year ended December 31, 2023, which included the return to provision adjustment that is generally updated at the completion of the third quarter of each fiscal year and an adjustment for partnership valuation. Also contributing to the differences between the effective tax rate and the federal statutory income tax rate was a permanent difference related to meals and entertainment.



The primary differences between the effective tax rate and the federal statutory income tax rate for 2022 resulted from a permanent difference related to penalties and fines incurred of $149.  Also contributing to differences between the effective tax rate and the federal statutory income tax rate were the adjustment for prior years’ estimates to actual that are generally updated at the completion of the third quarter of each fiscal year and were $86 in the year ended December 31, 2022. Other contributing factors to the differences between the effective tax rate and the federal statutory income tax rate were permanent differences related to meals and entertainment and the dividends-received deduction (“DRD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income.



Deferred tax assets and liabilities at December 31, 2023 and 2022 were comprised of the following:

   
2023
   
2022
 
Deferred tax assets:
           
Deferred acquisition costs
 
$
8,808
   
$
7,953
 
Net unrealized investment losses
    3,342       4,489  
Insurance reserves
   
2,898
     
1,597
 
Impaired assets
   
791
     
791
 
Bad debts and other
   
337
     
252
 
Net operating loss
    559        
Total deferred tax assets
   
16,735
     
15,082
 
Deferred tax liabilities:
               
Deferred and uncollected premiums
 
$
(1,053
)
 
$
(835
)
Net unrealized investment gains
           
Other
   
   
(84
)
Total deferred tax liabilities
   
(1,053
)
   
(919
)
Net deferred tax asset
 
$
15,682
   
$
14,163
 


The components of income tax expense (benefit) were:

   
2023
   
2022
 
Current – Federal
 
$
2,727
   
$
2,390
 
Deferred – Federal
   
(3,121
)
   
(1,819
)
Total
 
$
(394
)
 
$
571
 


The Company has formal tax-sharing agreements, and files a consolidated income tax return, with its subsidiaries. Tax years 2020, 2021 and 2022 are considered open tax years that remain subject to examination by the Internal Revenue Service.
Note 9.
Credit Arrangements


As expected, discontinuation of London Interbank Offered Rate (“LIBOR”) occurred on June 30, 2023 (“LIBOR Cessation Date”) and affected the rates used in the Company’s credit arrangements after that date. On March 15, 2022, the U.S. Congress enacted the Adjustable Interest Rate LIBOR Act (the “LIBOR Act”) to address LIBOR’s cessation and to establish a clear and uniform process for replacing the overnight and one-, three-, six- and 12-month tenors of USD LIBOR in existing contracts that do not provide for the use of a clearly defined or practicable replacement benchmark rate (“tough legacy contracts”).  Further, the Board of Governors of the Federal Reserve System issued regulations, 12 C.F.R. Part 253, “Regulations Implementing the Adjustable Interest Rate LIBOR Act (Regulation ZZ),” which relate to the LIBOR transition.


Bank Debt


On May 12, 2021, the Company entered into a Revolving Credit Agreement (the “Credit Agreement”) with Truist Bank as the lender (the “Lender”). The Credit Agreement provides for an unsecured $10,000 revolving credit facility that matures on April 12, 2024. Prior to July 1, 2023, the Company paid interest on the unpaid principal balance of outstanding revolving loans at the 1-month LIBOR Rate (as defined in the Credit Agreement) plus 2.00%, subject to a LIBOR floor rate of 1.00%. Effective July 1, 2023, the interest rate on the unpaid principal balance of outstanding revolving loans is determined based on a reference rate of the 1-month Term Secured Overnight Financing Rate (“SOFR”) published by Chicago Mercantile Exchange Group Benchmark Administration Limited (“CME”) (as defined in the Credit Agreement) plus a spread adjustment of 0.11448% plus 2.00%, subject to a SOFR floor rate of 1.00%.


The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35% of the Company’s consolidated capitalization at any time. The Credit Agreement also contains customary representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the Lender may, among other things, declare all obligations under the Credit Agreement immediately due and payable and terminate the revolving commitments. As of December 31, 2023 and 2022, the Company had outstanding borrowings of $3,019 and $2,009, respectively, under the Credit Agreement.


Junior Subordinated Debentures


The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities (“Trust Preferred Securities”) representing undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) of the Company; and (iii) engaging in those activities necessary or incidental thereto. At December 31, 2023, the effective interest rate was 9.69%.



The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company. Prior to July 1, 2023, the interest rate was based on 3-month LIBOR plus an applicable margin. The margin ranges from 4.00% to 4.10%. Effective July 1, 2023, the interest rate is determined based on a reference rate of the 3-month SOFR plus applicable tenor spread of 0.26161 percent plus an applicable margin, ranging from 4.00% to 4.10%.



The financial structure of each of Atlantic American Statutory Trust I and II, as of December 31, 2023 and 2022, was as follows:

 
Atlantic American
Statutory Trust I
   
Atlantic American
Statutory Trust II
 
JUNIOR SUBORDINATED DEBENTURES(1)(2)
         
Balance December 31, 2023
 
$
18,042
    $ 23,196  
Less: Treasury debt(3)
   
      (7,500 )
Net balance December 31, 2023
 
$
18,042
   
$
15,696
 
Net balance December 31, 2022
 
$
18,042
   
$
15,696
 
Coupon rate
 
3-Month SOFR + 0.26161 spread adj + 4.00%
    3-Month SOFR + 0.26161 spread adj + 4.10%  
Interest payable
  Quarterly     Quarterly  
Maturity date
  December 4, 2032     May 15, 2033  
Redeemable by issuer
  Yes     Yes  
TRUST PREFERRED SECURITIES
               
Issuance date
  December 4, 2002     May 15, 2003  
Securities issued
   
17,500
      22,500  
Liquidation preference per security
 
$
1
   
$
1
 
Liquidation value
 
$
17,500
   
$
22,500
 
Coupon rate
 
3-Month SOFR + 0.26161 spread adj + 4.00%
    3-Month SOFR + 0.26161 spread adj + 4.10%  
Distribution payable
  Quarterly     Quarterly  
Distribution guaranteed by(4)
 
Atlantic American Corporation
    Atlantic American Corporation

(1)
For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the debentures’ respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company’s common stock nor make any principal, interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated Debentures to be distributed to the holders of the Trust Preferred Securities.
(2)
The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.
(3)
In 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.
(4)
The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and upon dissolution, winding up or liquidation.

Note 10.
Leases


The Company has two operating lease agreements, each for the use of office space in the ordinary course of business. The first lease renews annually on an automatic basis and based on original assumptions, management is reasonably certain to exercise the renewal option through 2026. The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on September 30, 2026. The rate used in determining the present value of lease payments is based upon an estimate of the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease.


These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease expense reported for each of the years ended December 31, 2023 and 2022 was $1,014.


Additional information regarding the Company’s real estate operating leases is as follows:

   
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Other information on operating leases:
           
Cash payments included in the measurement of lease liabilities reported in operating cash flows
 
$
1,048
     
1,031
 
Right-of-use assets included in other assets on the consolidated balance sheet
   
2,614
     
3,405
 
Weighted average discount rate
   
6.8
%
   
6.8
%
Weighted average remaining lease term in years
  2.9 years     3.9 years  


The following table presents maturities and present value of the Company’s lease liabilities:

   
Lease Liability
 
2024
 
$
1,065
 
2025
   
1,083
 
2026
   
942
 
Thereafter
   
 
Total undiscounted lease payments
   
3,090
 
Less: present value adjustment
   
293
 
Operating lease liability included in accounts payable and accrued expenses on the consolidated balance sheet
 
$
2,797
 


As of December 31, 2023, the Company has no operating leases that have not yet commenced.

 Note 11.
Benefit Plans

Equity Incentive Plan


On May 1, 2012, the Company’s shareholders approved the 2012 Equity Incentive Plan (the “2012 Plan”). The 2012 Plan authorized the grant of up to 2,000,000 stock options, stock appreciation rights, restricted shares, restricted stock units, performance shares, performance units and other awards for the purpose of providing the Company’s non-employee directors, consultants, officers and other employees incentives and rewards for performance and service. The 2012 Plan expired on April 30, 2022, ten years after its effective date.  As such, no grants have been or will be made under the 2012 Plan on or after its expiration, but outstanding awards granted thereunder will continue in accordance with their terms.



On May 24, 2022, the Company’s shareholders approved the 2022 Equity and Incentive Compensation Plan (the “2022 Plan”). The 2022 Plan authorizes the grant of up to 3,000,000 stock options, stock appreciation rights, restricted shares, restricted stock units, performance shares, performance units and other awards, and succeeded the 2012 Plan for the purpose of providing the Company’s non-employee directors, consultants, officers and other employees incentives and rewards for performance and service.



During the year ended 2023, there were no restricted shares issued under the 2022 Plan. During the year ended 2022, a total of 40,000 restricted shares, with an estimated fair value of $122 were issued under the 2022 Plan, and a total of 25,000 restricted shares, with an estimated fair value of $71 were issued under the 2012 Plan. The estimated fair value of the restricted shares issued was based on the common stock price at date of grant. Stock grants are generally issued from treasury shares. Vesting of restricted shares generally occurs after a one to three year period following the date of grant. The Company accounts for forfeitures as they occur. There were no stock options granted or outstanding under the 2022 Plan in 2023 or 2022. There were no stock options granted or outstanding under the 2012 Plan in 2022.



Shares available for future grant under the 2022 Plan at December 31, 2023 and 2022 were 2,960,000.


401(k) Plan


The Company initiated an employees’ savings plan (the “Plan”) qualified under Section 401(k) of the Internal Revenue Code in May 1995. The Plan covers substantially all of the Company’s employees. Effective January 1, 2009, the Company modified the Plan such that the Plan would operate on a safe harbor basis. Under the Plan, employees may defer up to 50% of their compensation, not to exceed the annual deferral limit. The Company’s total matching contribution for 2023 and 2022 was $283 and $255, respectively, and consisted of a contribution equal to 35% of up to the first 6% of each participant’s contributions. In addition to the matching contribution, the Company also provided a 3% safe harbor non-elective contribution in 2023 and 2022 of $629 and $569, respectively. All contributions were made in cash. Participants are 100% vested in their own contributions and the vested percentage attributable to certain employer contributions is based on a five-year graded schedule.

Agent Stock Purchase Plan


The Company initiated a nonqualified stock purchase plan (the “Agent Stock Purchase Plan”) in May 2012. The purpose of the Agent Stock Purchase Plan is to promote and advance the interests of the Company and its shareholders by providing independent agents who qualify as participants with an opportunity to purchase the common stock of the Company. Under the Agent Stock Purchase Plan, payment for shares of common stock of the Company is made by either deduction from an agent’s commission payment or a direct cash payment. Stock purchases are made at the end of each calendar quarter at the then current market value.

 Note 12.
Preferred Stock


The Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding at December 31, 2023 and 2022, respectively. All of the shares of Series D Preferred Stock are held by an affiliate of the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a par value of $1 per share and a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends, on the Series D Preferred Stock of $18 at December 31, 2023 and 2022. During each of 2023 and 2022, the Company paid Series D Preferred Stock dividends of $399.

Note 13.
Earnings Per Common Share


Basic earnings per share was computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. The computation of diluted earnings per share reflected the effect of potentially dilutive securities.


A reconciliation of the numerator and denominator of the income per common share calculations is as follows:

    For the Year Ended December 31, 2023  
    Income
   
Weighted
Average Shares
Outstanding
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Loss Per Common Share
                 
Net loss before preferred stock dividends
 
$
(171
)
   
20,404
     
-
 
Less preferred stock dividends
   
(399
)
   
         
Net loss applicable to common shareholders
 
$
(570
)
   
20,404
   
$
(0.03
)

   
For the Year Ended December 31, 2022
 
   
Income
   
Weighted
Average Shares
Outstanding
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Earnings Per Common Share
                 
Net income before preferred stock dividends
 
$
1,525
     
20,390
     
-
 
Less preferred stock dividends
   
(399
)
   
         
Net income applicable to common shareholders
 
$
1,126
     
20,390
   
$
0.06
 


The assumed conversion of the Company’s Series D Preferred Stock was excluded from the earnings per common share calculation for 2023 and 2022 since its impact would have been antidilutive.

 Note 14.
Statutory Reporting


The assets, liabilities and results of operations have been reported on the basis of GAAP, which varies in some respects from statutory accounting practices (“SAP”) prescribed or permitted by insurance regulatory authorities. The principal differences between SAP and GAAP are that under SAP: (i) carrying value of certain investments differ on a GAAP versus SAP basis, such as fixed maturities that are shown at amortized cost for SAP versus fair value for GAAP (ii)  certain assets that are non-admitted assets are eliminated from the balance sheet; (iii) acquisition costs for policies are expensed as incurred, while they are deferred and amortized over the estimated life of the policies under GAAP; (iv) the provision that is made for deferred income taxes is different than under GAAP; (v) the timing and methodology of establishing certain reserves is different than under GAAP; (vi) reinsurance is shown net on balance sheet for SAP and (vii) certain valuation allowances attributable to certain investments are required under SAP such as asset valuation reserve and interest maintenance reserve.


The Company meets the minimum capital requirements in the states in which it does business. The amount of reported statutory net income and capital and surplus (shareholders’ equity) for the Parent’s insurance subsidiaries for the years ended December 31 was as follows:

   
2023
   
2022
 
Bankers Fidelity, net income
 
$
7,017
   
$
3,865
 
American Southern, net income
   
3,964
     
5,743
 
Statutory net income
 
$
10,981
   
$
9,608
 
                 
Bankers Fidelity, capital and surplus
 
$
38,299
   
$
36,672
 
American Southern, capital and surplus
   
51,774
     
53,023
 
Statutory capital and surplus
 
$
90,073
   
$
89,695
 


Under the insurance code of the state in which each insurance subsidiary is domiciled, dividend payments to the Parent by its insurance subsidiaries are subject to certain limitations without the prior approval of the applicable state’s Insurance Commissioner. The Parent received dividends of $8,400 and $7,200 in the years ended 2023 and 2022, respectively, from its subsidiaries. In 2024, dividend payments to the Parent by the insurance subsidiaries in excess of $8,757 would require prior approval.
Note 15.
Related Party Transactions


In the normal course of business the Company has engaged in transactions with entities affiliated with the controlling shareholder of the Company. These transactions include the leasing of office space, certain investing and financing activities, as well as inconsequential administrative and consulting services. At December 31, 2023, two members of the Company’s board of directors, including the Company’s Chairman, President and Chief Executive Officer, were considered to be affiliates of the majority shareholder.


The Company leases approximately 49,586 square feet of office and covered garage space from one such controlled entity. During the years ended December 31, 2023 and 2022, the Company paid $1,199 and $880, respectively, under this lease.   In December 2022, Delta Life Insurance Company, the owner of the building, transferred title to the building to 4370 Peachtree LLC. Each of Delta Life Insurance Company and 4370 Peachtree LLC is controlled by an affiliate of the Company.



Certain financing for the Company has also been provided by this entity in the form of an investment in the Series D Preferred Stock (See Note 12). During the years ended December 31, 2023 and 2022, the Company paid this entity $399 in dividends on the Series D Preferred Stock.


Certain members of the Company’s management and board of directors are shareholders and on the board of directors of Gray Television, Inc. (“Gray”). As of December 31, 2023 and 2022, the Company owned 880,272 shares of Gray Class A common stock and 106,000 shares of Gray common stock. The aggregate carrying value of these investments in Gray at December 31, 2023 and 2022 was $8,490 and $10,772, respectively.


In each of the years ended December 31, 2023 and 2022, Gray paid the Company approximately $2,050 and $1,708 in insurance premiums related to certain voluntary employee benefit plans.

Note 16.
Segment Information


The Parent’s primary insurance subsidiaries operate with relative autonomy and each company is evaluated based on its individual performance. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. Substantially all revenue other than that in the corporate and other segment is from external sources.

   
For the Year Ended December 31, 2023
 
   
American
Southern
   
Bankers
Fidelity
   
Corporate
& Other
   
Adjustments
& Eliminations
   
Consolidated
 
Insurance premiums, net
 
$
68,443
   
$
110,382
   
$
   
$
   
$
178,825
 
Insurance benefits and losses incurred
   
51,015
     
71,485
     
     
     
122,500
 
Expenses deferred
   
(8,689
)
   
(9,320
)
   
     
     
(18,009
)
Amortization and depreciation expense
   
8,389
     
8,050
     
509
     
     
16,948
 
Other expenses
   
17,046
     
39,262
     
21,875
     
(12,264
)
   
65,919
 
Total expenses
   
67,761
     
109,477
     
22,384
     
(12,264
)
   
187,358
 
Underwriting income
   
682
     
905
     
            1,587  
Net investment income (loss)
   
4,507
     
5,755
     
3,325
     
(3,529
)
   
10,058
 
Other income (loss)
   
7
     
7
     
8,738
     
(8,735
)
   
17
 
Subtotal
   
5,196
     
6,667
     
(10,321
)
   
     
1,542
 
Net realized gains
   
     
70
     
     
     
70
 
Unrealized losses on equity securities
   
(111
)
   
(2,015
)
   
(51
)
   
     
(2,177
)
Income (loss) before income taxes
 
$
5,085
   
$
4,722
   
$
(10,372
)
 
$
   
$
(565
)
Total revenues
 
$
72,846
   
$
114,199
   
$
12,012
   
$
(12,264
)
 
$
186,793
 
Intangibles
 
$
1,350
   
$
1,194
   
$
   
$
   
$
2,544
 
Total assets
 
$
149,236
   
$
203,079
   
$
146,585
   
$
(117,635
)
 
$
381,265
 

   
For the Year Ended December 31, 2022
 
   
American
Southern
   
Bankers
Fidelity
   
Corporate
& Other
   
Adjustments
& Eliminations
   
Consolidated
 
Insurance premiums, net
 
$
70,276
   
$
115,164
   
$
   
$
   
$
185,440
 
Insurance benefits and losses incurred
   
47,175
     
76,281
     
     
     
123,456
 
Expenses deferred
   
(10,161
)
   
(12,867
)
   
     
     
(23,028
)
Amortization and depreciation expense
   
10,240
     
9,452
     
498
     
     
20,190
 
Other expenses
   
20,082
     
37,337
     
17,432
     
(9,714
)
   
65,137
 
Total expenses
   
67,336
     
110,203
     
17,930
     
(9,714
)
   
185,755
 
Underwriting income
   
2,940
     
4,961
     
            7,901  
Net investment income (loss)
   
4,147
     
5,414
     
2,461
     
(2,090
)
   
9,932
 
Other income (loss)
   
3
     
8
     
7,624
     
(7,624
)
   
11
 
Subtotal
   
7,090
     
10,383
     
(7,845
)
   
     
9,628
 
Net realized gains (losses)
   
(28
)
   
58
     
     
     
30
 
Unrealized losses on equity securities
   
(449
)
   
(6,629
)
   
(484
)
   
     
(7,562
)
Income (loss) before income taxes
 
$
6,613
   
$
3,812
   
$
(8,329
)
 
$
   
$
2,096
 
Total revenues
 
$
73,949
   
$
114,015
   
$
9,601
   
$
(9,714
)
 
$
187,851
 
Intangibles
 
$
1,350
   
$
1,194
   
$
   
$
   
$
2,544
 
Total assets
 
$
144,455
   
$
195,028
   
$
140,661
   
$
(113,080
)
 
$
367,064
 

Note 17.
Commitments and Contingencies

Litigation


From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and arising in the ordinary course of its business. In the opinion of management, any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.

Regulatory Matters


Like all domestic insurance companies, the Company’s insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business. Statutes typically delegate regulatory, supervisory, and administrative powers to state insurance commissioners. From time to time, and in the ordinary course of business, the Company receives notices and inquiries from state insurance departments with respect to various matters. In the opinion of management, any such known regulatory matters are not expected to have a material effect on the financial condition or results of operations of the Company.


Note 18.
Subsequent Events


On April 1, 2024, the Company announced that the board of directors declared an annual cash dividend of $0.02 per share of common stock that is payable to shareholders of record at the close of business on April 12, 2024.


On March 22, 2024, the Company entered into a First Amendment (the "Amendment") to its Revolving Credit Agreement (as amended, the “Credit Agreement”) with Truist Bank as the lender (the “Lender”). The Amendment, among other things, (a) updates the interest rate provisions to memorialize that the Company pays interest on the unpaid principal balance of outstanding revolving loans at the Adjusted Term SOFR rate (as defined in the Credit Agreement), plus 2.00%, (b) extends the maturity date of the revolving credit facility to March 22, 2027 and (c) requires that the Company maintain a consolidated net worth of not less than $64.2 million. Except as modified by the Amendment, the existing terms of the Credit Agreement remain in effect.


On February 21, 2024, a third-party service provider the Company utilizes for certain medical network claims data identified a cybersecurity incident, resulting in disruption of services.  In response to the incident the Company examined our data and systems thoroughly and has not detected any breach of our systems.  Subsequent to the incident, the Company transitioned to an alternative service provider as a permanent solution. We do not believe the cybersecurity incident at our third-party service provider materially affected or is reasonably likely to materially affect the Company or our business strategy, results of operations, or financial condition.


Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.
Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. The Company’s internal control over financial reporting system has been designed to provide reasonable assurance regarding the reliability and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management recognizes that there are inherent limitations in the effectiveness of any internal control system. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Furthermore, the application of any evaluations of effectiveness on future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that disclosure controls and procedures were not effective as of that date due to a material weakness in internal control over financial reporting described below.

Management’s Report on Internal Control Over Financial Reporting

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 based upon the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in the updated 2013 Internal Control – Integrated Framework. Based on that evaluation, management believes that internal control over financial reporting as such term is defined in Exchange Act Rule 13a-15(f) was not effective as of December 31, 2023, as a result of the material weakness described below.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

As a result of management’s evaluation, we identified certain deficiencies in internal control that we believe rise to the level of a material weakness.  Specifically, management determined that the design of the controls surrounding the process of reviewing insurance reserves and deferred acquisition costs within the Company’s life and health segment was not effective.  This deficiency in design did not enable the timely detection of anomalies in these values at the level of precision necessary to detect misstated values that may be material.

Notwithstanding these deficiencies, management believes that, because of the actions taken by management in identifying, and to address and correct, these deficiencies prior to the completion and filing of this Annual Report on Form 10-K, and the effective operation of other internal controls over financial reporting, the material weakness did not result in any identified material misstatements to our financial statements.  As a result, there were no changes to any of our historical financial statements.

Attestation Report of the Registered Public Accounting Firm

This Annual Report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to certain rules of the Securities and Exchange Commission that exempt non-accelerated filers, including the Company, from such requirement.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

The Company is currently in the process of remediating the material weakness as described above, which remediation efforts began in the quarter ended March 31, 2024 and include developing and implementing enhanced controls related to the review of values that are estimated using actuarial models.  The enhancements include implementing reviews at the product level where management evaluates, for each of the Company’s life and health products, the components of underwriting income and how they interrelate.  In addition, calculations that are independent from the actuarial models will, once fully developed, validate that the product parameters and actuarial assumptions are completely and accurately reflected within the actuarial models.

The Company has also initiated the development of an array of analytical reports that will help facilitate the timely detection of anomalous values within the Company’s life and health segment.  It is currently expected that these reports will be operational by September 30, 2024.  These reports will include reconciliations of actuarial values from quarter to quarter, utilizing values estimated via the actuarial models and values that are produced by accounting processes.

Inherent Limitations on Effectiveness of Controls

No system of controls, no matter how well designed and implemented, can provide absolute assurance that the objectives of the system of controls are met.  Furthermore, no evaluation of controls can provide absolute assurance that all control issues and any instances of fraud within a company have been detected.

Item 9B.
Other Information

None of the Company's directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2023, as such terms are defined under Item 408(a) of Regulation S-K.

Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

PART III

With the exception of certain information relating to the executive officers of the Company, which is provided in Part I hereof, the information relating to securities authorized for issuance under equity compensation plans and the information relating to the Company’s Code of Business Conduct and Ethics, each of which is included below, all information required by Part III (Items 10, 11, 12, 13 and 14 of Form 10-K) is incorporated by reference to the sections entitled “Election of Directors,” “Security Ownership of Certain Beneficial Owners and Management,” “Delinquent Section 16(a) Reports” (if applicable), “Executive Compensation,” “Certain Relationships and Related Person Transactions" and “Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm” to be contained in the Company’s definitive proxy statement in connection with the Company’s 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days of the Company’s fiscal year end.

Equity Compensation Plan Information

The following table sets forth, as of December 31, 2023, the number of securities issuable upon exercise of outstanding options, warrants and rights, the weighted average exercise price thereof and the number of securities remaining available for future issuance under the Company’s equity compensation plans:

Plan Category
 
Number of
Securities to Be
Issued Upon
Exercise of
Outstanding
Options,
Warrants
and Rights
   
Weighted-Average
Exercise Price
of Outstanding
Options,
Warrants
and Rights
   
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in the
First Column)
 
Equity compensation plans approved by security holders
   
   
$
     
2,960,000
 
Equity compensation plans not approved by security holders(1)
   
     
     
 
Total
   
   
$
     
2,960,000
 

(1)
All of the Company’s equity compensation plans have been approved by the Company’s shareholders.

Code of Business Conduct and Ethics

The Company has adopted a Code of Business Conduct and Ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or any persons performing similar functions, as well as its directors and other employees. A copy of this Code of Business Conduct and Ethics has been filed as an exhibit to this annual report on Form 10-K.

PART IV

Item 15.
Exhibits and Financial Statement Schedules

(a)
List of documents filed as part of this report:


1.
Financial Statements:

See Index to Financial Statements contained in Item 8 hereof.


2.
Financial Statement Schedules:

Schedule II - Condensed financial information of the registrant
Schedule III - Supplementary insurance information of the registrant
Schedule IV - Reinsurance information for the registrant
Schedule VI - Supplemental information concerning property-casualty insurance operations of the registrant

Schedules other than those listed above are omitted as they are not required or are not applicable, or the required information is shown in the financial statements or notes thereto. Columns omitted from schedules filed have been omitted because the information is not applicable.

  3.
Exhibits *:

Restated Articles of Incorporation of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 10-K for the year ended December 31, 2008].
Restated Bylaws of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed on March 4, 2016].
4.1
Description of the registrant’s common stock registered pursuant to section 12 of the Securities Exchange Act of 1934 [incorporated by reference to Exhibit 4.1 to the registrant’s Form 10-K filed on March 24, 2020].
10.01
Management Agreement, dated July 1, 1993, between the registrant and Atlantic American Life Insurance Company and Bankers Fidelity Life Insurance Company [incorporated by reference to Exhibit 10.41 to the registrant’s Form 10-Q for the quarter ended September 30, 1993].
Tax Allocation Agreement, dated as of January 4, 2016, between the registrant and the registrant’s subsidiaries [incorporated by reference to Exhibit 10.02 to the registrant’s Form 10-K for the year ended December 31, 2017].
Atlantic American Corporation 2012 Nonqualified Stock Purchase Plan [incorporated by reference to Exhibit 99.1 to the registrant’s Form S-8 (File No. 333-183207) filed on August 10, 2012].
Atlantic American Corporation 2012 Equity Incentive Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 10-Q for the quarter ended March 31, 2013].
Lease Agreement, dated as of November 1, 2007, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company [incorporated by reference to Exhibit 10.10 to the registrant’s Form 10-K for the year ended December 31, 2007].
First Amendment to Lease Agreement, dated as of March 31, 2008, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company [incorporated by reference to Exhibit 10.2 to the registrant’s Form 10-Q for the quarter ended March 31, 2008].
10.07
Assignment and Assumption of Leases and Contracts, dated as of December 21, 2022, by and between Delta Life Insurance Company and 4370 Peachtree LLC.
   
10.09
Revolving Credit Agreement, dated as of May 12, 2021, by and between Atlantic American Corporation and Truist Bank [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed with the SEC on May 13, 2021].
10.10**
Atlantic American Corporation 2022 Equity and Incentive Compensation Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed on May 31, 2022].
Code of Business Conduct and Ethics [incorporated by reference to Exhibit 14.1 to the registrant’s Form 10-K for the year ended December 31, 2003].
Subsidiaries of the registrant [incorporated by reference to Exhibit 21.1 to the registrant’s Form 10-K for the year ended December 31, 2015].
Consent of FORVIS LLP, Independent Registered Public Accounting Firm.
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
97.1
Atlantic American Corporation Compensation Clawback Policy
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH
Inline XBRL Taxonomy Extension Schema.
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase.
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase.
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase.
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase.
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

*
The registrant agrees to furnish to the Commission upon request a copy of any instruments defining the rights of security holders of the registrant that may be omitted from filing in accordance with the Commission’s rules and regulations.

**
Management contract, compensatory plan or arrangement.

Item 16.
Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   
ATLANTIC AMERICAN CORPORATION
   
(Registrant)
     
 
By:
/s/ J. Ross Franklin
   
J. Ross Franklin
   
Vice President and Chief Financial Officer
     
   
Date: April 1, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
         
/s/ Hilton H. Howell, Jr.
 
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
 
April 1, 2024
HILTON H. HOWELL, JR.
   
         
/s/ J. Ross Franklin
 
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
 
April 1, 2024
J. ROSS FRANKLIN
   
         
/s/ Robin R. Howell
 
Director
 
April 1, 2024
ROBIN R. HOWELL
   
         
/s/ Mark E. Preisinger
 
Director
 
April 1, 2024
MARK E. PREISINGER
   
         
/s/ Joseph M. Scheerer
 
Director
 
April 1, 2024
JOSEPH M. SCHEERER
   
         
/s/ Scott G. Thompson
 
Director
 
April 1, 2024
SCOTT G. THOMPSON
   
         
/s/ D. Keehln Wheeler
 
Director
 
April 1, 2024
D. KEEHLN WHEELER
   

Schedule II
Page 1 of 3

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

BALANCE SHEETS

ASSETS

   
December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Cash and cash equivalents
 
$
2,774
   
$
2,680
 
Investments
   
1,930
     
2,278
 
Investment in subsidiaries
   
117,637
     
113,079
 
Investments in unconsolidated trusts
   
1,238
     
1,238
 
Deferred tax asset, net     15,682       14,163  
Income taxes receivable from subsidiaries
   
1,988
     
1,951
 
Other assets
   
6,733
     
6,681
 
Total assets
 
$
147,982
   
$
142,070
 
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
 
                 
Other payables
  $
3,949
    $
4,130
 
Revolving credit facility
    3,019       2,009  
Junior subordinated debentures
   
33,738
     
33,738
 
Total liabilities
   
40,706
     
39,877
 
                 
Shareholders’ equity
   
107,276
     
102,193
 
Total liabilities and shareholders’ equity
 
$
147,982
   
$
142,070
 

See accompanying report of independent registered public accounting firm.


Schedule II
Page 2 of 3

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

STATEMENTS OF OPERATIONS

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Revenue
           
Fee income from subsidiaries
 
$
8,738
   
$
7,624
 
Distributed earnings from subsidiaries
   
8,400
     
7,200
 
Unrealized losses on equity securities, net
   
(51
)
   
(484
)
Other
   
(455
)
   
93
 
Total revenue
   
16,632
     
14,433
 
                 
General and administrative expenses
   
15,336
     
13,583
 
                 
Interest expense
   
3,269
     
1,952
 
     
(1,973
)
   
(1,102
)
Income tax benefit(1)
   
(4,802
)
   
(3,934
)
     
2,829
     
2,832
 
Equity in undistributed earnings of subsidiaries, net
   
(3,000
)
   
(1,307
)
Net income (loss)
 
$
(171
)
 
$
1,525
 

(1)
Under the terms of a tax-sharing agreement, income tax provisions for the subsidiary companies are computed on a separate company basis. Accordingly, the Company’s income tax benefit results from the utilization of the Parent’s separate return loss to reduce the consolidated taxable income of the Company.

See accompanying report of independent registered public accounting firm.


Schedule II
Page 3 of 3

CONDENSED FINANCIAL INFORMATION OF REGISTRANT
ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

STATEMENTS OF CASH FLOWS

   
Year Ended December 31,
 
   
2023
   
2022
 
   
(In thousands)
 
Cash flows from operating activities:
           
Net Income (loss)
 
$
(171
)
 
$
1,525
 
Adjustments to reconcile net income to net cash used in operating activities:
               
Unrealized losses on equity securities, net
   
51
     
484
 
Depreciation and amortization
   
509
     
515
 
Compensation expense related to share awards
   
119
     
134
 
Loss (earnings) from equity method investees
    294       (294 )
Equity in undistributed earnings of subsidiaries, net
   
3,000
     
1,307
 
(Increase) decrease in intercompany taxes
   
(37
)
   
220
 
Deferred income tax benefit
   
(3,123
)
   
(2,336
)
Decrease in accounts payable and accrued expenses
   
(181
)
   
(285
)
Other, net
   
(509
)
   
(1,348
)
Net cash used in operating activities
   
(48
)
   
(78
)
                 
Cash flows from investing activities:
               
Additions to property and equipment
   
(39
)
   
(45
)
Net cash used in investing activities
   
(39
)
   
(45
)
                 
Cash flows from financing activities:
               
Payment of dividends on Series D preferred stock
   
(399
)
   
(399
)
Payment of dividends on common stock
   
(408
)
   
(408
)
Proceeds from revolving credit facility, net
    1,000       2,000  
Treasury stock acquired — net employee share-based compensation
   
(12
)
   
(108
)
Net cash provided by financing activities
   
181
     
1,085
 
                 
Net increase in cash
   
94
     
962
 
Cash and cash equivalents at beginning of year
   
2,680
     
1,718
 
Cash and cash equivalents at end of year
 
$
2,774
   
$
2,680
 
                 
Supplemental disclosure:
               
Cash paid for interest
 
$
3,227
   
$
1,794
 
Cash paid for income taxes
 
$
2,582
   
$
2,764
 
Intercompany tax settlement from subsidiaries
 
$
4,031
   
$
3,946
 

See accompanying report of independent registered public accounting firm.


Schedule III
Page 1 of 2

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION

Segment
 
Deferred
Acquisition
Costs
   
Future Policy
Benefits,
Losses,
Claims and
Loss
Reserves
   
Unearned
Premiums
   
Other Policy
Claims and
Benefits
Payable
 
   
(In thousands)
 
December 31, 2023:
                       
Bankers Fidelity
 
$
41,150
   
$
116,141
   
$
2,561
   
$
1,132
 
American Southern
   
2,700
     
63,832
     
28,756
     
 
   
$
43,850
   
$
179,973
(1) 
 
$
31,317
   
$
1,132
 
                                 
December 31, 2022:
                               
Bankers Fidelity
 
$
39,880
   
$
110,238
   
$
2,814
   
$
1,255
 
American Southern
   
2,401
     
62,810
     
25,534
     
 
   
$
42,281
   
$
173,048
(2) 
 
$
28,348
   
$
1,255
 

(1)
Includes future policy benefits of $92,495 and losses and claims of $87,478.
(2)
Includes future policy benefits of $85,564 and losses and claims of $87,484.

See accompanying report of independent registered public accounting firm.

Schedule III
Page 2 of 2

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION

Segment
 
Premium
Revenue
   
Net
Investment
Income (Loss)
   
Benefits,
Claims,
Losses and
Settlement
Expenses
   
Amortization
of Deferred
Acquisition
Costs
   
Other
Operating
Expenses
   
Casualty
Premiums
Written
 
   
(In thousands)
 
December 31, 2023:
                                   
Bankers Fidelity
 
$
110,382
   
$
5,755
   
$
71,485
   
$
8,050
   
$
29,942
   
$
 
American Southern
   
68,443
     
4,507
     
51,015
     
8,390
     
8,356
     
71,665
 
Corporate & other
   
     
(204
)
   
     
     
10,120
     
 
   
$
178,825
   
$
10,058
   
$
122,500
   
$
16,440
   
$
48,418
   
$
71,665
 
                                                 
December 31, 2022:
                                               
Bankers Fidelity
 
$
115,164
   
$
5,414
   
$
76,281
   
$
9,295
   
$
24,627
   
$
 
American Southern
   
70,276
     
4,147
     
47,175
     
10,150
     
10,011
     
72,671
 
Corporate & other
   
     
371
   
     
     
8,216
     
 
   
$
185,440
   
$
9,932
   
$
123,456
   
$
19,445
   
$
42,854
   
$
72,671
 

See accompanying report of independent registered public accounting firm.

Schedule IV

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
REINSURANCE INFORMATION

   
Direct
Amount
   
Ceded to
Other
Companies
   
Assumed
From Other
Companies
   
Net
Amounts
 
Percentage
of Amount
Assumed
to Net
 
   
(Dollars in thousands)
 
Year ended December 31, 2023:
                               
Life insurance in force
 
$
814,241
   
$
(8,317
)
 
$
   
$
805,924
         
                                         
Premiums —
                                       
Bankers Fidelity
 
$
166,368
   
$
(55,993
)
 
$
7
   
$
110,382
     
0.0
%
American Southern
   
46,349
     
(5,902
)
   
27,996
     
68,443
     
40.9
%
Total premiums
 
$
212,717
   
$
(61,895
)
 
$
28,003
   
$
178,825
     
15.7
%
                                         
Year ended December 31, 2022:
                                       
Life insurance in force
 
$
670,610
   
$
(9,597
)
 
$
   
$
661,013
         
                                         
Premiums —
                                       
Bankers Fidelity
 
$
176,995
   
$
(61,839
)
 
$
8
   
$
115,164
     
0.0
%
American Southern
   
51,844
     
(6,546
)
   
24,978
     
70,276
     
35.5
%
Total premiums
 
$
228,839
   
$
(68,385
)
 
$
24,986
   
$
185,440
     
13.5
%

See accompanying report of independent registered public accounting firm.
Schedule VI

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION CONCERNING
PROPERTY-CASUALTY INSURANCE OPERATIONS

                                  
Claims and Claim
Adjustment
Expenses Incurred
Related To
                   
Year Ended

Deferred
Policy
Acquisition
Costs
   
Reserves
   
Unearned
Premiums
   
Earned
Premiums
   
Net
Investment
Income
   
Current
Year
   
Prior
Years
   
Amortization
of Deferred
Acquisition
Costs
   
Paid Claims
and Claim
Adjustment
Expenses
   
Premiums
Written
 
 

                                      (In thousands)  
December 31, 2023
 
$
2,700
   
$
63,832
   
$
28,756
   
$
68,443
   
$
4,507
   
$
47,658
   
$
3,357
 
$
8,390
   
$
48,144
   
$
71,665
 
                                                                                 
December 31, 2022
 
$
2,401
   
$
62,810
   
$
25,534
   
$
70,276
   
$
4,147
   
$
48,692
   
$
(1,517
)
 
$
10,150
   
$
42,948
   
$
72,671
 

See accompanying report of independent registered public accounting firm.

70


EXHIBIT 23.1

CONSENT OF FORVIS LLP
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
Atlantic American Corporation
Atlanta, Georgia

We consent to the incorporation by reference in the registration statements (Nos. 333-183207, 333-183210 and 333-265315) on Form S-8 of Atlantic American Corporation of our report dated April 1, 2024, with respect to the consolidated financial statements and schedules of Atlantic American Corporation as of and for the year ended December 31, 2023, which report appears in Atlantic American Corporation’s Annual Report on Form 10-K.

/s/ FORVIS, LLP
Atlanta, Georgia
April 1, 2024




EXHIBIT 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Hilton H. Howell, Jr., certify that:


1.
I have reviewed this annual report on Form 10-K of Atlantic American Corporation;


2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):


a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date: April 1, 2024
 
/s/ Hilton H. Howell, Jr.
     
Hilton H. Howell, Jr.
     
President and Chief Executive Officer




EXHIBIT 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Ross Franklin, certify that:


1.
I have reviewed this annual report on Form 10-K of Atlantic American Corporation;


2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.
 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
 designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
 designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
 disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):


a)
 all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date: April 1, 2024
 
/s/ J. Ross Franklin
     
J. Ross Franklin
     
Vice President and
     
Chief Financial Officer




EXHIBIT 32.1

Certifications Pursuant to §906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Annual Report on Form 10-K of Atlantic American Corporation (the “Company”) for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, that, to such officer’s knowledge:

  (1)
The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and


(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

 
Date: April 1, 2024
/s/ Hilton H. Howell, Jr.
   
Hilton H. Howell, Jr.
   
President and Chief Executive Officer
     
 
Date: April 1, 2024
/s/ J. Ross Franklin
   
J. Ross Franklin
   
Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.